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ABSTRACT 
     The purpose of this retrospective case-control study was to assess risk factors 
contributing to hospital acquired methicillin Staphylococcus aureus (HA-MRSA) and 
gain a better understanding of the burden of HA-MRSA infection in patients with spinal 
cord injuries. The study was also conducted to see if new information would be found on 
HA-MRSA infections and validate or refute current research for patients in a dedicated 
spinal cord injury unit at a Veterans Affairs Medical Center. During the study period, the 
infection control department identified 95 cases of HA-MRSA. Additional data 
retrospectively collected were basic demographics, admitting diagnosis, presence of 
varying comorbidities, ASIA score, presence of indwelling medical device, BMI, LOS, 
MRSA colonization, and quarterly hand hygiene compliance. The patient population was 
described using appropriate univariate descriptive statistics and crude odd ratios (ORs) 
with 95% confidence intervals (CIs) calculated. The most common sources of infection 
for cases were ulcer related (31.6%), from skin and soft tissue infections besides pressure 
ulcers (23.2%), 14.7% were Foley catheter related, 8.4% were blood stream infections 
and 22.1% were from other sites/sources. 
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Assessment of risk factors for HA-MRSA for spinal cord injury patients in this study 
found that colonization (OR: 3), device use (Foley OR: 3.3, PICC OR: 39.4, use of both 
OR: 21.1) , paralysis (1.9), ASIA score A (OR: 4.5), amputee (OR: 3.5), decubitus ulcer 
(OR: 7.1), length of hospital stay > 30 days (OR: 17.1) and a hand hygiene compliance 
</= .89 (OR:1.88) were each significantly associated with acquiring a HA-MRSA 
infection. The significant risk factors were found to be similar to those described in 
previous studies supporting the need for the MRSA bundle currently in place. The study 
also affirmed that this population has special medical needs and that hand hygiene 
compliance is correlated with infection and transmission of MRSA. This information will 
aid in strengthening the design of the infection control program currently in place.  
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CHAPTER 1 
PURPOSE and SIGNIFICANCE 
Introduction 
     Understanding the burden of healthcare-associated methicillin-resistant Staphylococcus 
aureus (HA-MRSA) in both healthcare and community settings is imperative for designing 
effective prevention programs and for the reduction of HA-MRSA infections (Centers for 
Disease Control and Prevention (CDC), 2011). Affecting certain populations disproportionately, 
such as individuals with low socioeconomic status and injection drug users; healthcare-
associated infections are among one of the top ten leading causes of preventable deaths within 
hospitals in the United States. Hospitals acquired infections (HAIs) result in increased morbidity 
and mortality and are also responsible for a substantial increase in healthcare costs each year 
(Klevens, Morrison, Nadle, Petit & Gershman et al., 2007). Because of the increased costs, and 
morbidity and mortality related to HAIs, the reduction of HA-MRSA has been a top priority in 
the United States for major stakeholders in the public health, the medical, and infection 
prevention communities (Agency for Healthcare Research & Quality (AHRQ), 2009; Centers for 
Medicare & Medicaid, 2009; CDC, 2007; The Institute for Healthcare Improvement, (IHI) 2006; 
Platt, 2011; Association for Professionals in Infection Control and Epidemiology, (APIC) 2009). 
Several of the major stakeholders include the CDC, APIC, the Institute of Medicine (IOM), and 
the AHRQ. Considered an emerging issue and a threat to public health, Healthy People 2020 
created a new goal, “...Prevent, reduce, and ultimately eliminate healthcare-associated infections 
(HAIs) (US Department of Health and Human Services, 2010). Reflecting the commitment to 
reducing healthcare-associated infections, two supporting objectives were created by Healthy 
People 2020: (HAI-1) reduce healthcare-associated infections by reducing central line associated 
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bloodstream infections; and (HAI-2) to reduce invasive healthcare-associated methicillin-
resistant Staphylococcus aureus infections by 75%  nationwide (US Department of Health and 
Human Services, 2010). 
     Another initiative to reduce HAIs and led by the World Health Organization (WHO) is part of 
the First Global Patient Safety Challenge. This program was launched in 2005 and in 2009 added 
additional goals and programs with an emphasis on hand hygiene. These programs were 
developed to support healthcare workers and improve hand hygiene compliance and thus support 
the prevention of often life threatening HAI (WHO), 2009).  
      In the last two decades MRSA has become the most commonly identified multi-drug 
resistant pathogen in the United States causing invasive infections and a fifth of the hospital 
acquired infections often resulting in longer hospital stays, increased morbidity and mortality and 
increased costs (Cosgrove, Yi, Kaye et al., 2005; Fairclough, 2008; Gould, 2006; Reed, 
Friedman, Engemann et al., 2005; Shorr, 2007; Shorr, Tabak, Gupta et al., 2006). Invasive 
infections caused by MRSA also result in poorer outcomes, increased recovery time, and higher 
re-infection rates than non-invasive infections (Boucher & Corey, 2008; Chambers, 2005; 
Cosgrove, 2005; Klevens, Edwards, & Gaynes, 2008; Liebowitz, 2009; Sakoulas, Perencevich, 
Schwaber, Karchemer, & Caremeli, 2003). 
      Purpose of Study 
      Over the past 20 years, the incidence of infections caused by antimicrobial-resistant 
pathogens has increased dramatically, especially in vulnerable high-risk populations, such as 
those patients in the intensive care unit (ICU) and those who are immunocompromised and 
debilitated (Croft, Mejia, Barker, Maxwell & Dart, et al., 2009; Sarikonda, Micek, Doherty, 
Reichley & Warren et al., 2010; Weber, Huang, Oriola, Huskins & Noskin et al., 2007). The 
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CDC has estimated a direct medical cost per patient of MRSA to be $27,083 to $34,900, 
assuming 120,000 MRSA infections per year, (Rojas & Liu, 2005) and with an estimated annual 
direct hospital cost of MRSA for the United States of $3.2 billion to $4.2 billion (American 
Health and Drug Benefits (AHDB), 2009). This burden to the healthcare system does not take 
into account the indirect costs of MRSA to the patient and society, lost income and lost 
productivity (AHBD, 2009).  In addition to the aforementioned costs, excess costs that are often 
associated with resistant pathogens may also be due to the necessity to use more expensive 
antibiotics, central venous access for prolonged infusion, additional laboratory monitoring, 
diagnostic testing and contact isolation for the patient (Shorr, 2007 ; Gould, 2010).  This leads to 
substantial medical costs and also an increased use of medical and personnel resources.  
     Healthcare-associated infections, or HAIs, have become the most common complication of 
hospital care according to the CDC (CDC, 2007; Scott, 2009).  Nearly 2 million patients suffer 
from infections annually with deaths resulting from HAI’s estimated to be 99,000 and health care 
costs often exceeding $28 to $33 billion annually (CDC, 2007 & Scott, 2009). Such infections 
were long accepted by clinicians as an inevitable hazard of hospitalization; however, recent 
efforts have demonstrated that by understanding the burden of MRSA in specific populations and 
hospital settings, implementing relatively simple measures such as hand hygiene, a majority of 
such infections can be prevented (Berwick, Calkins, McCannon & Hackbarth, 2006; Institute for 
Healthcare Improvement, 2006; McCannon, Schall, Calkins & Nazem, 2006; Weber, Sickbert-
Bennett, Brown & Rutala, 2007). As a result of these efforts and with present evidence showing 
healthcare-associated infections are preventable, hospitals and providers are under intense 
pressure to reduce the transmission and burden of these infections. Given the intense pressure 
upon hospitals to reduce HA-MRSA, predictors and risk factors for transmission and acquisition 
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of HA-MRSA have been addressed by a number of studies in hospital and community settings. 
Some of the predictors and risk factors addressed in these studies include such factors as MRSA 
colonization, previous hospitalization, and length of hospital stay (Croft et al., 2009; Klevens, 
Edwards, & Gaynes, 2008; Murthy & Frick, 2011; Ruhe et al., 2010; Santos, Machado, Camey, 
Kuchenbecker & Barth, 2010).  Additional studies focused on other possible risk factors and 
predictors associated with MRSA, such as hemodialysis, malnutrition and trauma (Kaye et al., 
2011).These risk factors have been used for surveillance purposes to target patient populations in 
different settings who may need specific interventions to prevent acquisition and transmission of 
HA-MRSA. Other variables that have been explored to be possible predictors and risk factors for 
infection and transmission of MRSA include invasive devices, age, chronic conditions such as 
hepatitis and HIV, and stays in long term care facilities (Evans, Hershow, Chin, Foulis & Burns 
et al., 2009; Garshick, Kelley, Cohen, Garrison, & Tun et al., 2005; Klevens, Edwards, & 
Gaynes, 2008). Comorbidities associated with MRSA infections and of interest because of an 
aging population include diabetes, decreased functional status and obesity (Chen et al., 2010; 
Eseonu, Middleton & Eseonu, 2011; Wang et al., 2010).  
     These infections are especially common in the intensive care unit (ICU) and acute care 
setting, therefore, recent studies have focused on preventing HAIs in these particular areas 
(Fortaleza, Melo, & Fortaleza, 2009; Kappel, Widmer, Geng, Arx & Frei et al., 2008; Rosenthal, 
Kyeremanteng, Hooper & Shojania, 2008; Scchweickert, Geffers, Farragher, Gastmeier, & 
Behnke et al., 2010). Because information is scarce and research has focused on preventing HAIs 
in these settings, a clear understanding of risk factors and predictors of MRSA transmission and 
acquisition is needed when attempting to translate this practice to patients with spinal cord 
injuries (Garcia, Moreno, Garrote & Cercenado, 2010; Kappel, Widmer, Geng, Arx & Frei et al., 
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2008).  
     Patients with spinal cord injuries are a unique population requiring long-term specialized 
care. Many of these patients suffer from chronic pain resulting in depression, anxiety, anger and 
substance abuse. Physical impairment from spinal cord injuries often cause chronic urinary tract 
infections, pressure ulcers, amputation, pneumonia, infections, pulmonary emboli and 
development of co-morbidities such as diabetes and cardiovascular disease, each impacting the 
patient’s engagement with treatment and motivation to recover and stay healthy. Therefore, 
understanding disease and infectious processes following this type of injury is necessary for 
customizing the appropriate treatment strategy as well as customizing infection control strategies 
for this population of patients (Evans et al., 2009). Addressing similarities and differences 
amongst different patient populations will also allow better patient care and improve patient 
safety.                                                  
      Significance of the Study 
     Healthcare – associated infections with MRSA have been an increasing concern in acute care 
Veterans Affairs (VA) Medical Centers. Previous efforts to reduce MRSA transmission and 
acquisition have been attempted with varying degrees of success; however, in 2007 an MRSA 
“bundle” was implemented in acute care VA hospitals nationwide in an effort to further decrease 
healthcare – associated infections and transmission of MRSA. In 2008, this same “bundle” 
approach was implemented within the VA in the spinal cord injury unit (SCIU).  The bundle 
consisted of universal nasal surveillance for MRSA, contact precautions for patients colonized or 
infected with MRSA, hand hygiene, and a change in the institutional culture whereby infection 
control would become the responsibility of everyone who has contact with patients.  
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     Past research suggests that infection and transmission rates have been reduced following 
implementation of preventive measures (APIC, 2007; Berwick, Calkins, McCannon & 
Hackbarth, 2006; CDC, 2007; Institute for Healthcare Improvement, 2006; McCannon, Schall, 
Calkins & Nazem, 2006) making this study important for several reasons. First, understanding 
the burden of HA-MRSA in patients with spinal cord injuries is important to this medical center 
in order to design an effective infection program tailored to the specific needs of this population 
to help prevent the transmission of MRSA and reduce HA-MRSA infections. Second, 
researchers have studied the transmission and acquisition of MRSA in similar populations and 
settings generalizing their results; however, what remains to be fully explored is how these risk 
factors and predictors affect patients in a spinal cord injury unit where information is scarce. And 
third, this research will provide new information on the topic of MRSA and validate previous 
studies that have assessed risk factors and predictors for acquiring an MRSA infection within the 
hospital environment. 
LITERATURE REVIEW 
Brief History of MRSA 
     Prior to the advent of antibiotics, Staphylococcus aureus (S. aureus) emerged as a bacterial 
pathogen that was capable of causing a variety of significant human diseases leading to a high 
fatality rate (Gordon & Lowy, 2008; Chambers, 2005). Sir Alexander Fleming discovered 
penicillin in the early 1900s however it was not until the 1940s that penicillin was introduced 
into clinical care increasing survival rates for people with Staphylococcal disease and other 
bacterial pathogens. Shortly after the introduction of penicillin into clinical use, Kirby published 
a report in 1944 describing penicillinase-producing strains of S. aureus from hospital patients 
(Chambers, 2001 & Kirby, 1944).  
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     Following World War II, penicillin became more readily available and used with increasing 
frequency within hospitals yielding a greater prevalence of penicillinase-producing strains of     
S. aureus. Within a few years most hospital strains of  S. aureus were resistant to penicillin 
(Chambers, 2001). Penicillinase is an enzyme S. aureus is capable of producing which has the 
ability to interfere with the beta-lactam ring on penicillin. This renders it ineffective against 
Staphylococci and produces resistance (Barber, 1961; Diagnostic Microbiology, 2011). By the 
early 1950s most hospital strains of S. aureus were beta-lactamase producing or resistant yet 
penicillin continued to be the drug of choice and recommended in the medical community 
throughout the 1970s as an effective antimicrobial against Staphylococcal disease (Chambers, 
2001). As these penicillin resistant strains emerged in the hospital setting -HA-MRSA, 
community strains of S. aureus continued to be sensitive to penicillin until the late 1990s.  
     Following the emergence of penicillin resistant strains of S. aureus in hospital settings, 
additional beta-lactam antimicrobials, or synthetic penicillins, were developed for the treatment 
of penicillin resistant S. aureus and included cloxacillin, methicillin, and nafcillin. The 
effectiveness of these antimicrobials was short lived - due to selective pressure of antibiotic 
exposure (Chambers, 2001) and by 1961 physicians in the United Kingdom reported seeing 
resistant strains to penicillin, streptomycin, tetracycline (Jevons, 1961), and methicillin (Barber, 
1961). These particular bacteria resistant to beta-lactam antimicrobials were later classified as 
methicillin-resistant Staphylococcus aureus (MRSA) (Emmanuel, 2008; Heymann, 2008) and 
were first reported among patients in the United States in 1968 at Boston Hospital (Barrett, 
McGhee, & Finland, 1968).  
     Four decades later and after the first reports of MRSA at Boston Hospital, MRSA is now a 
major public health problem causing recurrent infections and serious sequelae in even the 
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healthiest of individuals. MRSA is a very difficult pathogen to treat and is consistently reported 
in hospitals and communities in the United States with an increasing prevalence worldwide 
causing substantial morbidity, mortality, and cost (Boucher & Corey, 2008; Chambers, 2001; 
Derenski, 2005; Diekema & Climo, 2008; Payman & Thierry, 2008).  
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Table 1. Timeline of Staphylococcus aureus Infection and Resistance 
 
Year Event 
1940                                    
 
Penicillin introduced 
 
1942                                    
 
Penicillin-resistant Staphylococcus aureus appears 
 
1959                                    
 
Methicillin introduced; most S aureus strains in both hospital and community 
settings are penicillin resistant 
 
1961                                    
 
Methicillin-resistant S. aureus appears 
 
1963                                    
 
First hospital outbreak of methicillin-resistant S. aureus (MRSA) 
 
1968                                    
 
First MRSA strain in U.S. hospitals 
 
1970s                                  
 
Clonal spread of MRSA globally, very high MRSA rates in Europe 
 
1982                                  
 
4% MRSA rate in the United States 
 
1980s, early 1990s             Dramatic decreases in MRSA rates due to search-and- destroy;  By 1999, <1% 
MRSA rate in the Netherlands; that rate has been sustained to date despite 
increasing MRSA rates in other parts of  the world 
 
1996                                  
 
Vancomycin-resistant S.aureus (VRSA) reported in Japan 
 
1997                                   
 
Approximately 25% MRSA rate in US hospitals; vancomycin use increases; 
Serious community-acquired MRSA (CA-MRSA) infections reported; Pediatric 
deaths reported 
 
2002                                   
 
First clinical infection with VRSA in the United States 
 
2003 MRSA rates continue to increase; approx. 60% MRSA rate in intensive care 
units; outbreaks of CAMRSA reported in numerous community settings and 
also implicated in hospital outbreaks; 2006 >50% of staphylococcal skin  
infections seen in emergency departments caused by CA-MRSA; HA-MRSA 
rate continues to increase; Distinction between HA-MRSA and CA-MRSA on 
epidemiological basis becomes  increasingly difficult 
 
2007   Report of active, population-based surveillance for invasive MRSA done in 
2004-2005 estimates 95,000 invasive MRSA infections and 19,000 deaths from 
MRSA per year; Continued reports in the medical literature and media about 
severe CA-MRSA infections; Several states pass or are considering legislation 
regarding control of MRSA and public reporting of MRSA rates ; Strategies to 
control MRSA, including public reporting of MRSA  infections, are hotly 
debated; “staph” and MRSA become household words 
 
Mayo Clinic Proceedings, 2007 
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Community Acquired Methicillin-Resistant Staphylococcus aureus 
     In the last 10 years, MRSA has not only become a hospital pathogen, but also a community 
pathogen. CA-MRSA differs from HA-MRSA in that the infections may involve younger and 
healthier individuals without any known risk factors for infection or colonization (Boucher & 
Corey, 2008; CDC, 1999; Chambers, 2005; Kuehnert et al., 2005; Lui et al., 2008; Skov et al., 
2005). 
     Gaining national attention, the first cases of community-acquired MRSA infections where no 
known risk factors could be found were first reported in the United States in the late 1990s. 
These cases were among four young children under the age of 5 in Minnesota and North Dakota, 
each case was fatal (Centers for Disease Control and Prevention, (CDC), 1999; Herold et al., 
1998; Adcock et al., 1998). These children did not have any established risk factors such as 
recent hospitalization, prolonged antibiotic therapy or a relative working in a health-care setting. 
Subsequently these cases were treated with a beta-lactam antibiotic, cephalosporin, known to be 
an effective antibiotic for the treatment of S. aureus at the time. Laboratory reports confirmed 
MRSA, causing a delay in the use of appropriate antibiotic therapy and possibly contributing to 
the fatal outcomes of the children.  
     These cases represented a paradigm shift in the epidemiology of MRSA. Additional outbreaks 
followed these reported cases in other community settings and among diverse populations whom 
appeared to be at risk for infection but with no known risk factors. Reported  infections initially  
involved  skin and soft-tissue and were among prison inmates, injection drug users, men who 
have sex with men (MSM), military personnel, athletes, the medically underserved, and also 
children attending child-care facilities (Boucher & Corey, 2008; Gordon & Lowy, 2008; Klevens 
et al., 2006; Miller & Diep, 2008). Later, necrotizing pneumonia, fasciitis and sepsis were 
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reported as a result of CA-MRSA causing serious infections and fatalities (Francis et al., 2005); 
Miller et al., 2005; Mongkolrattanothai, Kahana, & Daum, 2003).  
     CA-MRSA has the ability to spread within households due to close confinement of family 
members. Those colonized with CA-MRSA often will experience repeated infections with CA-
MRSA representing 15%-74% of skin and soft tissue infections presenting to the U.S. 
emergency departments and most often seen in healthy children and young adults (Mileno, 2008; 
Orlovic & Smego, 2009).   
Colonization 
     Risk factors associated with MRSA colonization are well documented and include prolonged 
antibiotic exposure, previous or recent hospital admission or nursing home admission, recent 
outpatient visits, chronic illness, injection drug use or direct contact with an MRSA-colonized 
patient, healthcare worker or family member (Beam & Buckley, 2006; Chambers, 2001; Klevens 
et al., 2006; Orlovic & Smego, 2009). 
      Colonization for individuals with MRSA may be persistent or transient for months, with most 
patients remaining asymptomatic (Beam & Buckley, 2008; Sanford, Widmer, Bale, Jones & 
Wenzel, 1994). Colonization most often occurs within the nares or nostrils, as well as other body 
sites such as the axillae, groin, perineum and gastrointestinal tract (Gordon & Lowy, 2008). 
These bacteria do not pose a threat unless the integrity of the skin is breached, with a break in the 
skin, whether by shaving, surgery, aspiration, or through the insertion of a central line or 
catheter. Humans and animals are both natural reservoirs for MRSA (Chambers, 2001) with 
transmission of MRSA  primarily through direct person to person contact; however, there are 
documented cases of animal to human and human to animal transmission ( Juhasz et al., 2007; 
van Loo et al., 2007; Weese et al., 2005).  
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      In 2004 a survey from the National Health and Nutrition Examination Survey (NHANES) 
estimated that greater than 4 million individuals in the United States or approximately 1.5% of 
U.S. residents are colonized with MRSA in the anterior nares (Gorwitz, 2008).  Recently 
published studies have arrived at varying conclusions regarding colonization of MRSA and the 
association with MRSA infections.  
       Safdar and Bradley (2008) performed a systematic review and found in their study on 
patients with MRSA nasal colonization that the incidence and risk for subsequent infections with 
invasive MRSA is up to four times higher among carriers, particularly for patients in the 
Intensive Care Unit (ICU). Research by Croft et al. (2010) reported in their study that MRSA 
colonization was a predictor of subsequent infection among trauma patients and similarly, 
Schweitzer et al. (2008) found that previous MRSA colonization or infection was predictive of 
subsequent MRSA blood stream infections (BSIs). Datta & Huang (2008) studied the risk of 
infections and death due to MRSA in long-term carriers and found that individuals who are 
known to have “harbored MRSA for >1 year are at high risk for subsequent MRSA morbidity 
and mortality” (pg. 176). Accounting for 39% of the infections included pneumonia, soft tissue 
(14%), and central venous catheter infection (14%). 
     In 2003, Huang and Platt studied 209 adult patients colonized with MRSA and following 
review of infection-control records found that after discharge from the hospital, 29% developed 
infections over the next 18 months. The infections identified were bacteremia, pneumonia, soft 
tissue infection, and osteomyelitis. Eighty percent of the study patients with previous MRSA 
infection developed an MRSA infection in a new site with 49% developing an infection after 
hospital discharge. By contrast, Sarikonda et al. (2010) found that MRSA nasal colonization in 
EPIDEMIOLOGY of HA-MRSA 
  
 
13 
 
patients admitted to the ICU was a poor predictor for subsequent occurrence of MRSA lower 
respiratory tract infections and BSI. Klevens et al. (2006) reported identical findings.     
     Colonization and infection rates vary by setting such as the type of health-care facility, 
geographic location, and the population being studied (Davis, Stewart, Crouch, Florez & 
Hospenthal, 2004). Understanding prevalence of infection and colonization within one’s own 
health-care facility is important for identifying high risk populations and for customizing 
successful infection control programs necessary to prevent acquisition and transmission of 
MRSA to patients, employees, and family members. 
Transmission 
     Transmission of MRSA from environmental sources and hands is well documented in the 
literature. Microorganisms have the ability to live on human hands 2-60 minutes following 
contact with patients and/or a contaminated environment (WHO, 2009). Another portal of entry 
for bacteria is during the performance of high-risk patient care procedures such as surgery or the 
insertion of a central line. Each of these actions may contribute to the risk of HAIs and 
colonization. 
     Hospitals have long been known to harbor MRSA on fomites such as stethoscopes, bedside 
tables, pagers, charts, and beds (Huang, Mehta, Weed, & Price, 2006; Kassem, Sigler, & Esseili, 
2007; Miller & Diep, 2008). Computer keyboards are also known  reservoirs for contamination 
with MRSA not only in the hospital setting but also occurring in the community setting. In a 
pilot study examining the survival time of MRSA on hospital surfaces, Huang, Mehta, Weed, & 
Savor (2006) reported that MRSA has the ability to live on charts, bedside tabletops, and cloth 
curtains for 9-12 days. Any of these reservoirs can be sources for person to person transmission 
of MRSA resulting in infection and colonization. 
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     Previous research provides substantiated evidence on the various ways transmission of MRSA 
may occur within the hospital environment. Therefore, the VAMC is following guidelines 
provided by the CDC to reduce such transmissions and understands the importance in using 
certain evidence based practice interventions.  
MRSA Bundle 
     The Veterans Affair Medical Center implemented an “MRSA Bundle” consisting of universal 
nasal surveillance for MRSA, contact precautions for patients who are either colonized or 
infected with MRSA, a greater emphasis on hand hygiene compliance, and a change in employee 
behavior and organizational culture towards hospital acquired infections.  
     A bundle is characterized by the Institute for Healthcare Improvement (IHI) as a structured 
way of improving processes used for improving health outcomes based on evidence-based 
practices (Institute for Healthcare Improvement (IHI), 2006a). The VAMC implemented the 
MRSA bundle as a targeted infection control strategy to reduce methicillin-resistant S. aureus 
transmission and infection. Recent data supports the use of “bundles” of interventions to achieve 
successful reduction in MRSA transmission and infections (IHI, 2006b; Resar et al., 2005; 
Youngquist et al., 2007).  
     Prior to full implementation of the MRSA bundle, the VAMC introduced the concepts of the 
MRSA bundle to HCWs through the use of education, games, and contests. The VAMC also 
conducted focus groups to involve staff and determine how to implement the initiative using 
their ideas. Once full use of the MRSA bundle began, the MRSA coordinators collected the 
swabbing data and surveillance which was reported back monthly to the leadership. There were 
MRSA champions on each nursing unit to help move the initiative forward and disseminate 
information. 
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     During the implementation of the MRSA Initiative, the infection control program also placed 
an emphasis on hand hygiene. In addition to the interventions of the National VA Initiative, all 
clinical personnel were involved in a collaborative, intensive, and self-monitoring of hand 
hygiene compliance. Each clinical unit had a hand hygiene champion trained by the Infection 
Control Department to observe and report quarterly. Non-staff volunteers were enlisted, trained 
by Infection Control staff, and often deployed on nights or weekends as independent observers of 
hand hygiene compliance.  Patients and visitors were engaged in hand hygiene education and 
encouraged to practice hygiene.  
     Continuous improvement of these interventions is consistently being made within the VAMC 
to aid in the reduction of MRSA HAIs and colonization of patients during their hospital stay. The 
CDC recommends a bundle approach for the reduction of infections caused by multi-drug 
resistant organisms. For this strategy to be successful, it is important for the infection control 
department to have an understanding of their patient population, risk factors and prevalence of 
MRSA. This understanding will provide information to be used for educational purposes and 
improved infection control strategies. 
Contact Precautions 
    Controlling the spread of MRSA within the hospital often requires a multi-modal  
 
approach. Literature suggests that quality improvement for the reduction of MRSA  
 
transmission and infection cannot be achieved by using a single intervention; therefore, a 
combination of improvement strategies is the approach many hospitals are using, to include 
contact precautions (Boyce, 2001). 
      The CDC recommends contact precautions when the facility deems MRSA to be of special 
clinical and epidemiologic significance. Following these recommendations, when single-patient 
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rooms are available, the VAMC will assign priority for these rooms to patients with known or 
suspected MRSA colonization or infection with highest priority given to those patients who have 
conditions that may facilitate transmission or infection, such as uncontained secretions or 
excretions. When single-patient rooms are not available, the VAMC will cohort patients with the 
same MRSA in the same room or patient-care area. When cohorting or grouping patients with 
the same MRSA is not possible, the VAMC will place MRSA patients in rooms with patients 
who are at low risk for acquisition of MRSA and associated adverse outcomes from infection 
and those who are likely to have short lengths of stay. 
       The CDC recommends healthcare workers wear gloves whenever touching the patient's 
intact skin or surfaces and articles in close proximity to the patient (e.g., medical equipment, bed 
rails). In addition to gloves, a gown is to be worn upon entry into the room and removed prior to 
leaving the room. Hand washing should then be performed before leaving the patient-care 
environment and upon leaving ensure that clothing and skin do not contact potentially 
contaminated environmental surfaces. This could result in possible transfer of microorganisms  
to other patients or environmental surfaces after leaving the room. 
      Contact precautions are used to reduce the risk of transmission of pathogens to the healthcare 
worker or conversely; to reduce the chance of the healthcare worker serving as a vector for 
transmission to patients. Contact precautions require patient cohorting or single-bed rooms for 
patients, and wearing gloves and gown simultaneously prior to contact with a patient. These 
guidelines are used by many hospitals and recommended by the CDC. 
             Hand Hygiene 
     Semmelweis’ hypothesis in 1846 that the hands of healthcare personnel were the vector for 
spreading illness to some patients was initially rejected.  However, hand hygiene is now widely 
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accepted today and is integral to the prevention of health care associated infections. Multidrug 
resistant organisms (MDROs) are transmitted by healthcare workers due to inadequate hand 
hygiene, poor technique, or contamination of the environment, equipment or supplies (Allegranzi 
& Pittet, 2009). Transmission sometimes results in health-care associated infections that cause 
approximately 80,000 deaths annually and significantly increase morbidity, mortality, and costs.         
     Many hospitals currently use core prevention strategies developed by the CDC when 
implementing clinical guidelines used to improve patient safety. In 2007 the Department of 
Veterans Affairs instituted a directive implementing the National VA MRSA Initiative which 
outlined a bundle methodology to decrease the rates of MRSA hospital-acquired infection. 
During the implementation of the MRSA initiative, the infection control department placed an 
emphasis on hand hygiene. 
     In 2001, Stone posited “that the treatment effect is so great that if hand hygiene were a new 
drug it would be used by all” (pg. 280).  During patient care, healthcare worker's hands become 
progressively colonized with commensal flora as well as pathogens while interacting with 
patients (Pittet et al., 1999; WHO, 2009).  In the event of ineffective hand hygiene, the longer the 
duration of care, the higher the degree of hand contamination. Healthcare workers are often busy 
and may not wash their hands for a sufficient amount of time or not use an adequate amount of 
antibacterial solution leading to poor hand decontamination. When infection control strategies 
break down during the care of a single patient and/or between patients’ contact, microbial 
transfer is likely to occur.     
     Contamination of healthcare worker’s hands has been associated with numerous hospital 
acquired outbreaks of multi-drug resistant organisms due to cross transmission to patients and 
also to the environment (Sartor et al., 2000; Shafie, Alishaq, & Garcia, 2004).  Performing 
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proper hand hygiene during patient care is the most effective way and the simplest means in 
reducing and preventing HAIs. However, despite this simple measure, hand hygiene compliance 
among healthcare workers, especially physicians, remains suboptimal (Squires et al., 2013; 
Pincock, Bernstein, Warthman, & Holst, 2012). A number of studies have shown that HCWs 
compliance with hand hygiene is less than 50% and that of physicians often lower (Squires et al., 
2013).  Due to the complexities within the healthcare environment, hand hygiene compliance is 
often a difficult behavior to change and maintain over time. 
     Literature has documented a number of factors contributing to healthcare workers adopting 
hand hygiene or resisting change; however, barriers specific to physicians are not as well 
described.  In a cross-sectional survey of physicians by Pittet and colleagues (2004), adherence 
for physicians showed an average of approximately 57% hand hygiene compliance, higher than 
the 50% norm but varied across medical specialties. Reasons for adherence to hand washing at 
the individual level was associated with an awareness of being observed, the belief of being a 
role model for others, a positive attitude toward hand hygiene after patient contact, and easy 
accessibility to hand –rub solution. However, a limitation to this study was the direct observation 
of the physician washing their hands and this may have influenced the increased compliance.         
     Pittet and colleagues (2004) found perceived environmental barriers for non-adherence for 
physicians to include high workload activities associated with high risk for cross-transmission. 
Additionally, certain medical specialties such as anesthesiology, emergency medicine and 
surgery were shown to have lower compliance rates due to time constraints and complexities in 
performing the job. Additional studies have shown a myriad of environmental barriers related to 
non-adherence to hand hygiene compliance for nurses and other HCWs to include lack of access 
to sinks, difficulty locating products, empty dispensers, and also time constraints (Boyle et al., 
EPIDEMIOLOGY of HA-MRSA 
  
 
19 
 
2001; Squires et al., 2013). 
     On the individual or personal level, barriers described as risk factors for non-adherence 
included attitudinal beliefs, and skin irritation from repeated hand washing (Boyle et al., 2001; 
Squires et al., 2013). Another study focusing on nurses at the individual level and using a 
behavioral approach was described by Boscart and colleagues (2012) which identified 
motivational sources such as a person’s personal safety and their families’ safety to yield greater 
hand hygiene compliance. Additional motivational factors described in the study as important to 
nurses was to have individual feedback and self-monitoring to increase awareness and leading to 
greater compliance.      
     Good hand hygiene has for many years been considered the most important and cost effective 
means to help prevent the spread of HAIs, yet maintaining compliance over 50% continues to 
remain challenging for most hospital infection control departments. 
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Figure 1:  
5 Moments for Hand Hygiene (2009). 
 
 
   
Figure 1: World Health Organizations’ (WHOs’) 5 Moments for Hand Hygiene (2009). 
 
 
EPIDEMIOLOGY of HA-MRSA 
  
 
21 
 
MRSA Active Surveillance 
      Active MRSA surveillance in the hospital setting may be helpful in the identification of 
patients at risk for developing MRSA infections; that is, screening all patients on admission for 
MRSA colonization to identify which patients need to be placed in contact precautions to reduce 
the spread to healthcare workers, patients, and family members (Bruce et al., 2010; Jain et al., 
2011). Hospitals nationwide are facing declining reimbursement for HAIs and although MRSA 
surveillance is costly, studies show that successful programs can pay for themselves by reducing 
a patient’s stay in the hospital. HAIs can double the length of stay for patients depending on 
complications and the facility (McCune, 2012).  
     Much attention has been focused on multi-drug resistant organism at the national and state 
levels and via public media. Some policy makers are calling for universal screening in hospitals 
to reduce HA-MRSA by identifying those colonized upon admission to the hospital or prior to a 
surgical procedure in hopes of reducing infection (Weber et al., 2007). Universal screening using 
a rapid Polymerase Chain Reaction (PCR) method for MRSA is expensive and remains 
controversial due to the variability in reducing HA-MRSA  in the healthcare community (Murthy 
et al., 2010; Harbarth et al., 2008; Jeyaratnam et al., 2008; Keshtgar et al., 2008; Hardy et al., 
2010; Robicsek et al., 2008). 
      Harbarth et al. (2008) conducted a prospective interventional cohort study at a Swiss teaching 
hospital using a rapid screening method for patients at admission in combination with 
conventional infection control measures compared to a control group using only standard 
infection control measures. This study showed no reduction in MRSA HAIs when using 
universal screening in combination with contact precautions in surgical patients. Another study, 
randomized and with high baseline MRSA infection rates by Jeyaratnam et al. (2008) also failed 
EPIDEMIOLOGY of HA-MRSA 
  
 
22 
 
to show a reduction in HA- MRSA infection rates. The investigators used a similar rapid 
molecular technique versus the conventional culture method. 
     Conversely, Robicsek et al. (2008) conducted an observational study in a 3-hospital, 850-bed 
organization with approximately 40,000 annual admissions comparing rates of MRSA during 
and after hospital admission in three consecutive time periods. After a baseline year, all patients 
admitted to the ICU were screened for MRSA colonization using PCR for twelve months and 
followed by screening for all hospital admissions. Patients testing positive for MRSA were 
placed in contact precautions. After three years, the prevalence density of aggregate hospital-
associated MRSA disease per 10,000 patient-days at baseline and during ICU surveillance was 
8.9, 7.4 the second year and 3.9 after the third year. The result of this intervention was associated 
with a large reduction in MRSA infection during admission and thirty days after discharge.  
      Keshtgar and colleagues (2008) conducted a study targeting surgical patients using PCR 
testing prior to undergoing emergency and elective surgery in a teaching hospital. MRSA 
positive patients were started on suppression therapy of mupirocin nasal ointment and undiluted 
chlorhexidine gluconate body wash. Comparing means to the previous year, MRSA bacteraemia 
fell by 38.5% and MRSA wound isolates fell by 12.7%. The reduction in MRSA infection was 
possibly related to the quick turnaround time for reporting of MRSA and the ability to administer 
the appropriate surgical prophylaxis prior to surgery. 
      Huang et al. (2011) in an effort to control MRSA spread in a neonatal intensive care unit 
(NICU) implemented several infection control measures. These included enhanced hand hygiene, 
alcohol-based handrubs, active MRSA surveillance, and contact precautions. This resulted in a 
significant decrease in all types of MRSA infections and colonization, especially blood stream 
infections. 
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     Using a rapid molecular testing method for identification of patients colonized with MRSA 
upon admission is highly debated despite the quick turn-around time for the result. Using PCR is 
expensive, and results can vary depending on the facility, and adoption of the proposed method. 
Policymakers have tried to mandate the testing method, but with literature showing varying 
results in the value of the test and the reduction of HAIs, hospitals continue to have an option as 
to whether to continue to use conventional culture methods.  
Culture Change 
     Another component of the MRSA bundle is the incorporation of institutional culture change 
throughout the hospital which integrates communication, teamwork, and leadership so that 
infection control and patient safety becomes the responsibility of everyone involved in the care 
of patients. This is to ensure that all persons within the facility take part in infection control and 
prevention practices reflecting the needs and desires of patients, whether this is through teaching 
and education, or through practice. 
     A result of the culture change is that everyone is responsible for infection control and 
prevention practices not just the department of hospital infection control and epidemiology.  This 
additional component of the bundle can aid in the decrease in transmission of MRSA and a 
decrease in the MRSA bioburden in the environment within the healthcare facility.  
    Risk Factors for MRSA Infections 
Age 
     Numerous factors predispose patients to MRSA and most studies have shown a strong 
association with age and infection. Kuehnert et al. (2005), using discharge data, reported MRSA 
rates for septicemia, pneumonia, and other infections increase with patient’s age with most 
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diagnoses occurring in persons > 65 years of age. In the same study, patients <14 and 15-44 
years of age had higher MRSA hospitalization rates when compared with patients age 45-64  
and > 65 years of age. Overall, the MRSA rate increased with patient age. Klevens et al. (2008) 
also found an increase in MRSA infections among older adults aged > 65 years and in hospitals 
with < 200 beds. Blood stream infections increased significantly from 27.0% in the period 1990-
1994 to 54.1% during the time period of 2000-2004. Among children during these same time 
periods aged 0-18 years, the proportion of infections due to antimicrobial resistant organisms did 
not change.  
      Fridkin et al. (2005) found that children less than two years of age were significantly more 
likely to be diagnosed with CA-MRSA infections when compared to children of differing ages. 
Another study, by Payman & Delorme, (2008) in a medical center also reported a significant 
increase in the incidence of MRSA among young patients 6-25 years of age, as well as patients 
45-50, and the elderly, 86-90. No differences were found in males or females. 
     A study by Liu et al. (2008) found among San Francisco residents, persons aged 35-44 years 
of age and 45-54 years of age and older adults >85 years of age were at the greatest risk of 
infection caused by community onset of MRSA and with an annual incidence of hospital-onset 
MRSA infection to increase with age, especially the elderly. Men were 2.4 and 1.7 times more 
likely to have community-onset and hospital-onset MRSA than women, respectively. Again, 
combined hospital-onset and community-onset MRSA was three times higher in persons who 
were black versus white. 
          Numerous factors predispose patients to MRSA infections and most studies have shown a 
strong association with age and infection. Literature suggests those at highest risk include the 
young and the elderly with the chance of infection increasing as age increases. 
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Comorbidities and MRSA 
     Fridkin et al. (2005) identified underlying chronic conditions which increase a patient’s 
contact with healthcare workers and length of stay within the hospital as predisposing factors for 
either colonization or infection with MRSA disease. The chronic conditions identified by Fridkin 
include diabetes, cardiovascular disease (CVD), smoking, HIV infection, and alcohol abuse. 
Yates et al. (2009) concluded in their study that wound chronicity, inpatient care, and chronic 
kidney disease each independently predisposed patients to MRSA infection. Malani, et al. (2008) 
also found diabetes to be associated with higher MRSA infections as well as chronic pulmonary 
disease, and hypertension.  
     Many patients with spinal cord injuries have poor functional status. In a nested case-control 
study in patients 65 and older, researchers found that a high Charlson comorbidity score, 
immobility, and wound class each were independent predictors of MRSA surgical site infections. 
Kaye et al. (2011) studied predictors for bloodstream infections in a retrospective case-control 
study on patients age 65 and older and found such comorbidity factors as obesity, presence of a 
central line on admission, and urinary incontinence to be predictive of an MRSA infection. 
     A prospective cohort study on patients admitted to an intensive care unit (ICU) and staying 
for a minimum of two days were studied for HA-MRSA. Variables excluded from the study were 
those that could be assessed within 24 hours of admission to the ICU because HA- MRSA 
infection is usually determined after 48 hours.  Four variables found to be risk factors for MRSA 
infections in the ICU are intubation, open wound, antibiotic treatment, and steroid 
administration. These findings do not contradict other studies; however, intubation as a risk 
factor has not been fully explored (Yamakawa et al., 2011). 
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     Wang and colleagues (2010) conducted a large one year prospective study in a tertiary care 
center in Taiwan differentiating between HA-MRSA and CA-MRSA using molecular typing to 
identify predictors of infection. Using univariate analysis, age, ICU onset, length of stay before 
index culture, diabetes mellitus, bedridden status, recent surgery, and catheter-related infection 
were associated with HA-MRSA. Community onset (CA-MRSA) was isolated from soft tissue 
infections and deep-seated infection, and not related to a surgical procedure. The study used 
patients with positive blood cultures, or bacteremia. 
     Comorbidities can play a central role in the acquisition of a hospital acquired infection 
resulting in longer hospital stays, increased cost to the patient and often debilitating effects, if not 
death. Older adults are at higher risk because of the presence of multiple comorbid conditions, 
functional impairment and a reduced immune response. 
Invasive Devices 
     Invasive devices pose the greatest threat to patients for serious infections. The presence of an 
indwelling central venous catheter is the single strongest predictor of a bloodstream infection 
(Kaye et al., 2011), mechanical ventilators may cause serious respiratory infections and urinary 
catheters can result in catheter-associated urinary tract infections. 40% of the 2 million hospital 
associated infections reported each year are urinary tract infections and 80% of the infections are 
due to the presence of indwelling urinary catheters (Chen et al., 2013). 
     A retrospective case-control study was conducted by Kaye et al. (2011) to examine predictors 
of nosocomial bloodstream infections in older adults. In this study, of the 830 cases, 81% of the 
hospital-acquired blood stream infections were catheter related with 23% infected with MRSA, 
and MRSA was the most common pathogen isolated. Independent predictors of the catheter 
related blood stream infection (CRBSI) were male sex, obesity, the presence of a central line, a 
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gastrostomy tube, and urinary incontinence at the time of admission. The presence of the central 
line on admissions almost doubled the risk factor for a blood stream infection while the 
gastrostomy tube was associated with almost three times the risk. An unusual finding included an 
association with being male as an increased risk for infection however the reason for this was 
unclear and not discussed.  
     A prevalence study was conducted in patients with and without spinal cord injury to 
investigate the risk of hospital acquired infection by Girard, Mazoyer, Plauchu, & Rode (2006). 
The prevalence of infection was higher in the spinal cord injury group than in those without 
injury, 23.4% and 4.8% respectively, with most infections classified as urinary tract infection. 
Urinary catheterization is very common and significantly more frequent in spinal cord injury 
patients than non-spinal injury. The spinal cord injury group had a greater number of 
comorbidities; however, the only independent predictor of infection was having an indwelling 
urinary catheter. Other common infections found in this group included skin and soft tissue, 
often related to decubitus ulcers.       
       A retrospective case-control study by Yoon et al. (2010) from January 2006 to February 
2009 looked at predictors of persistent methicillin-resistant S. aureus bacteremia. In this case-
control study the researchers found independent factors associated  with MRSA bacteremia to be 
long term use of medical devices, such as central lines, MRSA infection in more than one site, 
and long term vancomycin treatment.  
     Another problem with indwelling devices is the chance for the patient to become colonized 
with a multiple drug resistant organism, such as MRSA. Considered high risk for infection, 
Mody et al. (2007) studied the relationship between the use of indwelling devices and 
colonization in patients from a nursing home facility. Of the 100 patients in the device group, 55 
EPIDEMIOLOGY of HA-MRSA 
  
 
28 
 
were colonized with MRSA at various sites, compared with 23 in the control group. Literature 
has shown an association with colonization as a risk factor and predictor for subsequent MRSA 
infection. 
     Patients considered high risk, such as those with a spinal cord injury, may develop serious 
infections due to the use of indwelling devices. Many patients with spinal cord injuries use 
intermittent catheterization or have an indwelling urinary catheter, require central line placement 
for treatment due to infection, or require mechanical ventilation. The most effective way to 
prevent infections related to devices is to reduce the incidence of use, ensure the device is 
clinically indicated and use evidence based guidelines for insertion. 
Hospital Length of Stay 
     Patients who remain in hospitals for extended lengths of time are exposed to longer 
antimicrobial use, invasive procedures and greater contact with healthcare workers. Past studies 
have suggested that each of these characteristics increases a patient’s chance to acquire MRSA; 
therefore, length of stay is a possible risk factor (Santos et al., 2010; WHO, 2009). Barnett and 
colleagues (2009) studied the effect of MRSA infection on the length of stay in an intensive care 
unit and found that patients with MRSA infections had a relative risk of discharge when 
compared to staying that was approximately 20% lower than that for patients without MRSA. 
Contributing factors for the additional stay was found to be attributed to how ill the patient was, 
the number of comorbidities present, and if the infections were occurring early during their stay 
in the ICU. Prolonged stays in the ICU not only impacted the risk of infection but was shown to 
be associated with a slight risk in mortality.  
     Another study associated with poor outcomes related to MRSA and hospital length of study 
was conducted by Eseonu, Middleton, & Eseonu (2011). The study was conducted in a major 
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orthopedic trauma center in surgical patients over an 11 year study period. Length of stay for 
patients admitted was found to be significantly associated with an adverse outcome when the 
LOS was greater than 30 days. 62% of these patients suffered an adverse outcome compared to 
24% that did not. Other studies have suggested a higher incidence of post-operative infections in 
males, yet this study with 38% of the cohort being male and 62% female, found no association 
between gender and outcomes. The mean age within the group with a good outcome was 71, 
while the mean age of the adverse outcome group was 69; this is contrary to the findings in 
previous work. Patients with diabetes and the site of the infection were not found to have a 
significant association with a poor outcome either. 
      Looking at trends in hospitalizations with antibiotic-resistant infections in the US, 1997-
2006, Mainous et al. (2011) used national hospital discharge data to study the length of stay for 
infection related hospitalizations. From 1999-2000 the length of stay rose at first and then began 
a decline from 1997-2006, totaling an overall 40% decline with a median stay of 6.62 and 3.97 
days, respectively. The study’s results also suggested that length of stay in the hospital was 
closely related to the presence of health insurance. As the proportion of patients without 
insurance with infection-related hospitalizations with antibiotic resistance increased, the length 
of stay for those patients without insurance decreased, showing a median length of stay of 4.15 
days. Patients with health insurance during the 10-year period had a median length of stay of 
5.49 days; therefore suggesting the mean length of stay was shorter for patients without health 
insurance. 
     Patients who remain in hospitals for extended lengths of time are exposed to longer 
antimicrobial use, invasive procedures, greater contact with healthcare workers and the hospital 
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environment. Each of these factors may contribute to a patient acquiring a hospital related 
infection increasing a patient’s morbidity and mortality. 
Quality Improvement and Patient Safety Movement 
      Over the last ten years patient safety has become a top priority in hospitals, emphasizing the 
importance of effective surveillance and prevention activities performed by infection control 
programs. In the mid 1800s, Florence Nightingale emerged as the first infection prevention and 
control champion in the healthcare industry. Nightingale believed in preventive medicine 
resulting in the creation of standardized methods for cleaning hospitals. Around the same time, 
Dr. Ignaz Semmelweis discovered that simple hand washing could prevent the spread of bacteria 
from patient to patient, reducing infections and amputations, as well as deaths. Semmelweis' 
colleague, Oliver Wendell Holmes also made a similar discovery yet both physicians were 
criticized by their peers regarding their findings due to skepticism. Another milestone in 
reducing infections involved the surgeon, Joseph Lister, publishing ground breaking work on 
antisepsis and is credited as being the first person to use a sterilization process in the operating 
room and therefore reducing the spread of infection amongst patients (Smith, Watkins, & 
Hewlett, 2012). 
      In the 1960s, hospital surveillance began due in large to the emergence of S. aureus in 
hospitals. Surveillance has since evolved as an important component of infection control 
programs used for identifying the sources causing hospital outbreaks,  identification of problem 
areas in the hospital environment, and for setting priorities for infection control activities. 
Surveillance data is also used to provide feedback to staff and physicians regarding infection 
rates and trends and can lead to action for reduction of hospital acquired infections.  
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     In the 1970s, the National Nosocomial Infection Surveillance (NNIS) was created for the 
purpose of collecting, analyzing, and disseminating data on HAIs and to standardize definitions 
for infections. The SENIC project, which was a Study on the Efficacy of Nosocomial Infection 
Control, published in 1974, found that one third of HAIs could be prevented by effective 
infection control programs and by the 1990's, the Healthcare Infection Control Practices 
Advisory Committee (HICPAC) was formed by the CDC. This committee has been instrumental 
in establishing standardized guidelines used by infection control programs throughout U.S. 
hospitals resulting in improved quality processes and a reduction in HAIs.  
     In 1999, the Institute of Medicine published Today's Patient Safety and Quality Initiatives 
which reported on adverse events in hospitals, deaths, and the costs related to these adverse 
events. Recommendations resulting from this report included a proposal for hospital infection 
control programs to establish Patient Safety programs making the job of reducing HAIs and 
providing a safe work environment for all employees a top priority. A number of organizations 
are involved in the Patient Safety movement such as the Joint Commission on Accreditation of 
Healthcare Organizations and the Institute of Medicine. National Patient Safety Goals were 
developed by the Joint Commission and currently must be followed for hospital accreditation. 
Several examples of the goals infection control are responsible for overseeing include the 
monitoring of hand hygiene practices, development of methods for prevention of catheter related 
bloodstreams infections and eventually mandatory reporting of HAIs. A recent quality initiative 
developed by the Institute for Healthcare Improvement (IHI) is the "bundle." This type of 
measure is used by the VAMC for the reduction of MRSA HAIs. The bundle consists of 
improved hand hygiene, contact isolation, universal surveillance, and culture change within the 
hospital setting.  
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     Improving the quality of patient care through surveillance and prevention activities is a 
valuable asset provided by infection control programs. Over the last ten years a greater emphasis 
has been placed on reducing such adverse events as HAIs caused by MRSA. Proposed guidelines 
can aid infection control programs in reducing infections, deaths, and the cost related to each of 
these.                                                                 
Summary 
      Prior to 1970, infections resulting from MRSA were uncommon in hospital settings. By the 
1980s and 1990s reports of HA-MRSA steadily increased, and by 1998 CA-MRSA was first 
reported among young children with no known risk factors (Mileno, 2008). Over the past 20 
years, the incidence of infections caused by antimicrobial-resistant pathogens has increased 
dramatically, especially in vulnerable high-risk populations, such as those patients in the 
intensive care unit (ICU) and those who are immunocompromised and debilitated (Croft et al., 
2009; Sarikonda et al., 2010; Weber et al., 2007). The CDC has estimated a direct medical cost 
per patient of MRSA to be $27,083 to $34,900. Assuming 120,000 MRSA infections per year, 
(Rojas & Liu, 2005) there is an estimated annual direct hospital cost of MRSA for the United 
States of $3.2 billion to $4.2 billion (American Health and Drug Benefits, 2009).  
     Because of the increased costs, and increased morbidity and mortality, the reduction of HA-
MRSA has been a top priority in the United States for major stakeholders in the public health, 
medical, and infection prevention communities (Agency for Healthcare Research & Quality, 
2009; Centers for Medicare & Medicaid, 2009; CDC, 2007; The Institute for Healthcare 
Improvement, (IHI) 2006; Platt, 2011; Association for Professionals in Infection Control and 
Epidemiology, 2009). As a result of these efforts by major stakeholders and with present 
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evidence showing healthcare-associated infections are preventable, hospitals and providers are 
under intense pressure to reduce the transmission and burden of these infections. 
      Individual interventions, such as universal surveillance or greater compliance with hand 
hygiene are unlikely to work alone as effective measures in reducing MRSA transmission and 
acquisition. Reduction in the number of HAIs and transmission of MRSA within the hospital 
setting requires a comprehensive approach for successful outcomes and sustainability, and for 
establishing guidelines and criteria for hospital infection control and quality improvement.  
Use of Theory 
      The theories used in this study include the Theory of Reasoned Action (TRA) and the Theory 
of Planned Behavior (TPB), frequently referred to as TRA/TPB. To provide specificity and to 
show the strength of the theory, each theory is discussed in detail with definitions of the 
constructs and examples related to infection control practice. The study was informed by theory 
for the development of research questions related to hospital acquired infections.  
    A theory that has received considerable attention in regards to health behavior change and 
proposes that the most important determinant of a person’s behavior is a person’s intent, is the 
Theory of Reasoned Action by M. Fishbein (Fishbein, 1967). This theory was designed to study 
volitional behaviors or those behaviors that are performed at will (Luszczynska & Sutton, 2005).  
Along with Fishbein, Icek Ajzen proposed four constructs within this theory which helped them 
to develop the conceptual framework. These constructs include: intention, belief, behavior and 
attitude.  Behavioral intention is defined by Fishbein and Ajzen as, “an indication of a person’s 
readiness to perform a behavior and it is considered an immediate antecedent of 
behavior”(Ajzen, 2006). Behavioral belief is a person’s intent to perform a behavior and the 
consequence that is related to performing the behavior and their subjective norms (social 
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pressures) associated with the behavior.  Attitude toward the behavior is “the degree to which 
performance of the behavior is positive or negatively valued,” (Ajzen, 2006). This is determined 
by a group of accessible behavioral beliefs linking the behavior to various outcomes. In the 
context of infection control practices, if a healthcare worker feels a strong commitment toward 
good patient care and to reduce infections through proper hand hygiene compliance, as a result, 
this person will have a positive attitude towards this task each time it needs to be performed. The 
opposite is true as well, negative beliefs about infection control practices, such as the need to 
wash hands repetitively and causing an irritation to the HCWs hands or a lack of understanding 
of the risk of infection, might yield low hand washing compliance.  
     Subjective norm “is the perceived social pressure to engage or not engage in a behavior” 
(Ajzen, 2006). A few examples of the type of social pressure a healthcare worker may 
experience which influences the behavior are social networks within the hospital and include 
peers, co-workers, physicians, or infection control managers. Therefore, if a person is concerned 
about what other people may think or are concerned about another person’s perception of their 
job performance, this may provide motivation for a person to follow recommended guidelines for 
hand washing, and for insertion, cleaning, and maintenance of devices. This is a positive 
subjective norm and the person believes they are performing the appropriate behavior. The 
opposite of this thought process is true as well. An example of a positive subjective norm related 
to infection control practice may include healthcare workers who view co-workers or physicians  
as important people in their lives. They also believe these people, through observation, approve 
of their actions and participation in following appropriate infection control practices such as 
hand washing compliance. Each of the examples described above are behaviors that are purely 
volitional and may predict behavioral intention and the actual behavior.  
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     In 1991 Ajzen expanded the Theory of Reasoned Action by adding an additional construct 
related to self-efficacy, perceived behavioral control, to create the Theory of Planned Behavior. 
These are not two different theories, rather a modification of the Theory of Reasoned Action 
reflecting those behaviors that are not fully under volitional control, or behaviors not performed 
at will. This modification reflects upon the perception by the healthcare worker as to whether or 
not an action, or job is within reason or difficult to perform. A person’s behavior is strongly 
influenced by their confidence (self-efficacy) and their ability to perform a behavior. A 
healthcare worker may view a task as difficult and these difficulties are perceived as barriers 
when performing some infection control practices, such as hand washing. The reasons for these 
perceptions may include the thought of repetitive hand washing as very time consuming and 
taking away from other important patient care duties, or a lack of resources to perform the job. 
     These theories inform the research to understand the behaviors of healthcare workers towards 
infection control measures, such as compliance with hand hygiene recommendations to aid in the 
reduction of HAIs (McLaws,  Mahariouei, & Askarian, 2012; Pittet, 2004; O’Boyle, Henly & 
Larson, 2001). 
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Figure 2. 
TRA/TPB Related to Hospital Acquired Infections 
Intention 
 
 
 
 
HCW’s plan to adhere to hand hygiene in a 
variety of clinical settings for reduction of 
hospital acquired infections 
 
Attitude 
 
 
 
Affective/cognitive evaluation of the hand 
hygiene procedure itself  
 
Beliefs about outcomes Cognitive evaluation of the consequences of 
poor hand hygiene including transmission of 
the bacteria and professional behavior 
 
Subjective norm Overall evaluation of the extent to which 
important people in the lives of HCWs are 
thought to support or endorse hand  hygiene 
compliance as recommended 
Normative beliefs 
 
 
 
Beliefs about expectations that specific other 
people hold for the HCW’s person hand 
hygiene compliance 
Perceived control 
 
 
 
Overall evaluation of the degree to which a 
HCW believes that hand hygiene compliance 
can be performed as recommended 
Control beliefs 
 
 
 
 
The extent to which a HCW believes that he or 
she possesses or has access to resources 
required to adhere to hand hygiene compliance 
in a variety of clinical settings 
 
Figure 2. Constructs of the TRA/TPB 
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Figure 3. 
TRA/TPB & Hand Washing Compliance for Reduction of HA-MRSA    
Infections 
 
 
 
 
 
 
                                                                                       
                                                                                
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Subjective Norm 
Normative Belief: Motivation to 
comply with hand washing 
because of peers/coworkers 
expectations-peer pressure  
 
Attitude 
Behavioral Belief: Cognitive 
evaluation of the consequences 
of poor hand hygiene leading to 
transmission of bacteria to 
patients 
Perceived Behavioral Control 
Control Belief: The extent to 
which a HCW believes that he or 
she possess or has access to 
resources required to adhere to 
hand hygiene compliance within 
the hospital environment 
Behavior 
HCWs compliance with 
hand washing based on 
hospital recommendations 
 
 
 
Intention 
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DEFINITION OF TERMS 
Adverse Outcome- An injury that was caused by medical personnel 
American Spinal Injury Association (ASIA) Impairment Scale – Level of spinal cord injury, 
 usually from A-D. 
 A=Complete: No motor or sensory function is preserved in the sacral segments S4-S5 
 B=Incomplete: Sensory but not motor function is preserved below the neurological level  
  and includes the sacral segments S4-S5 
 C=Incomplete: Motor function is preserved below the neurological level, and more than  
  half of key muscles below the neurological level have a muscle grade less than 3 
 D=Incomplete: Motor function is preserved below the neurological level, and at least half 
  of key muscles below the neurological level have a muscle grade of 3 or more 
 E=Normal: Motor and sensory function are normal       (www.asia-spinalinjury.org/) 
Bioburden-The number of bacteria living on a surface before it is sterilized 
Carrier – Organism that harbors an agent without clinical disease 
Case – A patient meeting the defined hospital acquired infection definition as defined by CDC,  
 VHA, APIC, or other national authority  
Chromogenic Agar – An agar used for the isolation and identification of methicillin - resistant 
 Staphylococcus aureus 
Colonization – Microorganisms become established in a host without causing infection/disease 
Cohort - Group of patients that share the same room or floor 
Eschar– A thick leathery crust often covering an underlying necrotic process  
Foley Catheter –  A small flexible tube inserted into the urethra to the bladder to allow for the 
 drainage of urine 
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Fomite – An inanimate object or material that is capable of transmitting infectious organisms 
 from one individual to another 
Hawthorne Effect – Phenomenon that produces an improvement in human behavior or 
 performance as a result of increased attention from superiors or colleagues; a temporary 
 modification of behavior 
Incidence – Number of new cases of a disease a specific population has during a period of time 
Infection – A condition whereby the bacterium has invaded body tissue and is multiplying and 
 causing manifestations of disease, such as fever 
Infection Control Measures – In addition to Standard Precautions, Transmission Based 
 Precautions Contact Precautions for Methicillin Resistant Staphylococcus aureus or 
 Clostridium difficile  
Invasive – Characterized by a tendency to spread, infiltrate and intrude 
Methicillin – An antibiotic in the penicillin class used in the past to treat infections from 
 Staphylococcus aureus 
Methicillin-Resistant Staphylococcus aureus (MRSA) – A gram positive bacteria that is resistant 
 to  methicillin or oxacillin and many other antibiotics 
Methicillin-Sensitive Staphylococcus aureus (MSSA) – A gram positive bacteria that is sensitive 
 to methicillin or oxacillin 
MRSA Bundle – Consist of contact isolation, hand hygiene, universal surveillance, & culture 
 change within the hospital setting 
Nares – The nostrils (openings) of the nose which allow inhalation and exhalation of air 
Nosocomial – Originating or taking place in a hospital 
Pathogen – An agent such as bacteria capable of causing disease 
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Penicillinase – Producing Staphylococcus aureus – a bacterium resistant to beta-lactam 
 antibiotics, particularly methicillin  
PICC Line – A form of intravenous access that can be used for a prolonged period of time, such 
 as for extended antibiotic therapy. It is inserted through a peripheral vein and advanced 
 until the tip of the catheter reaches the Superior Vena Cava 
Polysubstance abuse – Refers to a type of substance dependence disorder in which an individual 
 uses at least three different classes of substances indiscriminately  
Positive Deviance – Using one's own experiences to find solutions and solve problems while still 
 following established hospital MRSA Infection Control Policies 
Pressure Ulcer – Also known as decubitus ulcers or bedsores are localized injuries to the skin 
 and/or underlying tissue usually over a bony prominence as a result of pressure, or  
 pressure in combination with shear and/or friction. This most often occurs on the sacrum, 
 coccyx, heels or the hips.     
Prevalence – The total number of existing cases of a specified disease in a given population 
 during a given period of time    
Staphylococcus aureus – Bacterial species which can colonize or infect a person  
Slough– Dead skin tissue that may have a yellow or white appearance             
Surveillance – A system of collecting, consolidating, and analyzing resident data to determine 
 incidence and prevalence of a disease in a facility 
Transmission (MRSA) – The transfer of a disease from one person to another. The main mode of 
 transmission of MRSA is person to person via hands.  
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ACRONYMS 
APIC – Association of Practitioners of Infection Control 
BSIs – Blood Stream Infections 
CDC – Centers for Disease Control and Prevention 
ICU – Intensive Care Unit 
IOM – Institute of Medicine 
IHI – Institute for Healthcare Improvement 
LOS – Length of Stay 
MDROs – Multidrug Resistant Organisms 
MSSA – Methicillin-sensitive Staphylococcus aureus 
MRSA – Methicillin resistant Staphylococcus aureus  
NICU – Neonatal Intensive Care Unit 
PICC Line – Peripherally Inserted Central Catheter Line 
VAMC– Veterans Affairs Medical Center 
VHA – Veterans Health Administration 
WHO – World Health Organization 
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CHAPTER 2 
 RESEARCH QUESTIONS 
 Research Questions 
Question 1 - What is the burden of HA-MRSA infection in patients with a spinal cord injury? 
Question 2 - Is there an association with MRSA and age, race, weight, ASIA Score, decubitus 
ulcer, diabetes mellitus, anxiety/depression, Hepatitis C, polysubstance abuse, alcohol use, 
paraplegia, quadriplegia, amputee, device use, MRSA colonization, length of stay and hand 
hygiene compliance? 
Question 3 - What evidence from this study will validate previous studies on MRSA risk factors? 
Question 4 - What new information will emerge from this study? 
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CHAPTER 3 
METHODS AND MATERIALS  
 
Purpose of the Study 
 
     The purpose of this case-control study was to assess risk factors contributing to HA-MRSA 
and gain a better understanding of the burden of HA-MRSA in patients with spinal cord injuries. 
The case-control study was also conducted to see if new information would be found on HA-
MRSA infections and validate or refute current research on the topic for patients in a dedicated 
spinal cord injury unit at a Veterans Affairs Medical Center. 
Design of the Study 
 
     After obtaining Institutional Review Board approval from Georgia Regents University and the 
Veterans Affairs Medical Center, data were made available from the VHA Infection Control 
Department and permission granted for medical chart review.  
     The study was a retrospective chart review (case-control) study to gain a better understanding 
of trends in MRSA colonization and infection. The intent was to provide researchers and the VA 
Infection Control and Epidemiology Department with a better understanding of possible risk 
factors associated with the acquisition and transmission of MRSA in a dedicated spinal cord 
injury unit for fiscal years 2008-2011. 
    Inclusion and Exclusion Criteria 
      Those included in this study were male inpatients in the spinal cord injury unit 18 years of 
age and older. No minors were included in the study. Subject selection criteria were purely 
driven by the population of inpatients. It fairly distributes the burden, risk, and benefits of the 
research as it is generated by factors specific to the pathogen and the environment that are 
beyond the control of the researcher. 
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     Patients may have diminished capacity due to advanced dementia or other advanced or end-
stage medical problems. This same vulnerability is why they are susceptible to hospital acquired 
infections and why much care must be taken to try to prevent them. The potential benefit from 
lessons learned from surveillance and epidemiology outweighs the risk of the analysis and data 
gathering that will use the medical records of these patients. 
           Data Source 
     The Veterans Affair Medical Center implemented a “MRSA Bundle” consisting of universal 
nasal surveillance for MRSA, contact precautions for patients who were either colonized or 
infected with MRSA, hand hygiene, and a change in the institutional culture using positive 
deviance. The goal of positive deviance was to foster cultural change so that HCWs would help 
find solutions to solve problems and therefore infection control and prevention became the 
responsibility of everyone involved in the care of patients.  
     The electronic medical record for this study was initially established when a patient was 
admitted to the hospital and followed until the patient was discharged or the patient expired. 
“The Veterans Health Administration (VHA) utilizes a sophisticated electronic health 
information system called the Veterans Health Information Systems and Technology 
Architecture (VISTA). This system is a comprehensive clinical and administrative repository of 
all veteran health information including laboratory, radiology and pharmacy. The computerized 
patient record system (CPRS) is a system that provides a user interface for information captured 
in VISTA. Health care providers use the CPRS & VISTA to update patient medical history, 
place clinical orders, review laboratory results, medical images and current medications. 
Microbiological culture data and relevant patient information are obtained from VISTA via a  
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Clinical Informatics Service in the VA, which is responsible for extracting data from VISTA into 
a relational database (SQL server).” (VHA, 2007) 
    Collection of MRSA Nasal Swabs 
     Samples of nasal secretions are obtained by hospital staff with a swab from both anterior 
nares of patients within 24 hours after their admission to the hospital. Swabs are also obtained 
from patients who are not known to be colonized or infected with MRSA when they are 
transferred or discharged from units within the VA. The VA clinical microbiology laboratory 
processes the nasal swabs with the used of standard or selective chromogenic agar for the 
isolation of MRSA or with polymerase chain-reaction (PCR) based tests by rapid molecular 
detection for the detection of the organism. Positive results are reported to the patient’s nursing 
unit and recorded in the electronic medical record. 
        Study Population 
The study population included male adults 18 years of age and older who had a hospital 
admission to the Spinal Cord Injury Unit between fiscal years 2008-2011 at a Veterans Affair 
Medical Center in the southeastern U.S. No minors were included in the study. Racial/ethnic 
composition did not limit enrollment. Subject selection criteria were purely driven by the 
population of inpatients. It fairly distributed the burden, risk, and benefits of the research as it 
was generated by factors specific to the pathogen and the environment and are beyond the 
control of the researcher.                                    
    Analysis and Interpretation of the Data 
      Data Collection 
      A retrospective case-control study was conducted. Hospital acquired MRSA infections were 
identified by the Infection Control Department through routine surveillance. Once the case 
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definition was met a line-list of cases was made which was added to a spreadsheet with name 
and SSN and kept on a protected department network drive in the Infection Control Department. 
Validation of the MRSA cohort and collection of variables was performed on these cases using 
the computerized patient record system (CPRS) and the Veterans Health Information Systems 
and Technology Architecture (VISTA). Database managers extracted the CNVAMC control-
group subjects from the spinal cord injury unit for years 2008-2011 using the last 4 digits of the 
SSN, name and birth year. For every MRSA case, 2 controls were randomly chosen and 
stratifying on birth year. This 2:1 selection was used to improve the power of the study. All data 
was de-identified before analysis. We extracted the following variables for both cases and 
controls: demographic information (gender, race/ethnicity, birth year), reason for visit (admitting 
diagnosis), length of stay, presence of comorbidities, ASIA score, CA-MRSA on admission and 
discharge, and infection source and type. All personally identifiable information was deleted 
before entry into a spreadsheet for analysis of the data. A new ID was created for this purpose for 
each patient that had no link to the SSN or name and transferred to a disc by the CNVAMC data 
managers. Data was not stored on the hard drive of a PC and no mobile devices were used.  
    Collection of Hand Hygiene Data 
     Hand hygiene records were collected per routine surveillance by the Infection Control 
Department. Hand hygiene data for HCWs is reported quarterly and kept protected on the access 
limited committee or department network drive in the Infection Control and Epidemiology 
Department.   
      Collection of hand hygiene data for HCWs in the Spinal Cord Injury Unit was observational 
and used both staff and independent monitors. The data was reported quarterly to the Infection 
Control Department as part of routine surveillance. A minimum of ten opportunities to wash 
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hands or use alcohol-based hand rub was observed by each department/unit and reported as a 
percentage for the quarter. 
     Coding for this variable was entered in the following way: the four quarters in the year were 
coded as 1-4 respectively; each patient was assigned a percentage based on the hand hygiene 
compliance for the quarter the patient was admitted. 
    Collection of MRSA Case Subjects 
      MRSA cases were identified as part of routine surveillance by the Infection Control 
Department. Once the case definition of MRSA-HAI infection, CA-MRSA infection or 
colonization was met as defined by the CDC & the National Health Safety Network (NHSN), a 
line-list of cases was made which was kept on protected department network drives. The data 
was then de-identified before entry into a spreadsheet by VA Infection Control Practitioners and 
was kept protected on the access limited committee drive or department network drive. Data was  
further protected by keeping electronic information password protected and access limited and 
other documents locked in filing cabinets in the PI’s research office. Investigators had access to 
these materials. 
     Data Analysis 
      Prior to the data analysis, time was spent in "cleaning" the data and performed in several 
stages. In the first step, variables were reviewed by looking at variances and frequencies, 
outliers, coding errors, missing data, typing errors and subsequently checked with the medical 
records. Also, the number of cases and controls were reviewed to make sure the number of cases 
matched the number of controls. In the second stage, corrections were made, and the analysis 
performed.  
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      The patient population of interest was described using appropriate univariate descriptive 
statistics: frequencies and percentages for categorical variables and means, medians and range 
and standard deviation for continuous variables and crude odd ratios (ORs) and 95% confidence 
intervals (CIs) were calculated. All statistical analyses were done using IBM SPSS Statistics 
(IBM Corp. Released 2011. IBM SPSS Statistics for Mac, Version 20.0. Armonk, NY: IBM 
Corp.). 
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CHAPTER 4 
              RESULTS 
     The purpose of this case-control study was to assess risk factors contributing to HA-MRSA 
and gain a better understanding of the burden of HA-MRSA in patients with spinal cord injuries. 
The case-control study was also conducted to see if new information would be found on HA-
MRSA infections and validate or refute current research on the topic for patients in a dedicated 
spinal cord injury unit at a Veterans Affairs Medical Center.  
     This chapter is organized into the following sections to present study results: (1) descriptive 
analysis for variables of interest, and; (2) analysis of research questions. 
    Descriptive Statistics for Variables of Interest 
     During the study period, the infection control department identified 95 cases of HA-MRSA 
using standard surveillance methods and criteria for HAIs as defined by the CDC and the NHSN. 
All cases were validated by the researcher using these criteria and a data collection tool was 
constructed before study initiation. Culture information collected by the Infection Control 
Department included the source, type and date of infection. Additional data that were 
retrospectively collected were basic demographics, admitting diagnosis, presence of varying 
comorbidities, ASIA score, presence of indwelling medical device, BMI, LOS, MRSA 
colonization on admission and discharge, and quarterly hand hygiene compliance. 
     Ninety-five cases of HA-MRSA were identified and 190 uninfected control patients were 
chosen using a random number generator. The mean age of the cohort on admission was 59.81 
(+/- 11.77 S.D.), had a mean BMI of 26.56 (+/- 6.521 S.D.) and had a mean length of stay of 
83.17 days (+/- 123 S.D.) (Table 2). Note that amputees were excluded from all BMI 
calculations because of the questionable significance of the value. 
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Table 2. Quantitative Variable Descriptive Statistics Overall and by Group 
 
 
 
  
Cases 
 
Control 
 
Overall 
Age on 
Admission 
    
 N Valid 93 190 283 
 N Missing 2 0 2 
 Mean 59.89 59.77 59.81 
 Median 61.00 61.00 61.00 
 Std. Dev. 11.818 11.775 11.768 
 Minimum 25.000 26.000 25.000 
 Maximum 84.00 84.00 84.00 
     
BMI1     
 N Valid 76 168 244 
 N Missing 2 11 12 
 Mean 25.99 26.82 26.56 
 Median 26.00 27.00 26.00 
 Std. Dev. 5.992 6.748 6.521 
 Minimum 15.000 15.000 15.000 
 Maximum 46.000 53.000 53.000 
     
LOS2     
 N Valid 94 190 284 
 N Missing 1 0 1 
 Mean 165.77 42.31 83.17 
 Median 128.50 10.00 29.00 
 Std. Dev. 152.497 78.481 123.056 
 Minimum 4.000 1.000 1.000 
 Maximum 934.000 549.000 934.000 
     
Hand Hygiene N Valid 95 189 284 
 N Missing 0 1 1 
 Mean .607579 .664603 .645528 
 Median .670000 .890000 .860000 
 Std. Dev. .3832385 .4167471 .406028 
 Minimum .0000 .0000 .0000 
 Maximum 1.0000 1.0000 1.0000 
     
1Body Mass Index (Amputees Excluded) 
2Length of Stay (Days) 
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    Primary causes of spinal cord injury varied across cases and controls with the majority of 
injuries caused by vehicular (Approx. 25.0 % for cases and controls), and motorcycle accidents 
(9.5% for cases vs. 4.7% for controls), falls (24.2% for cases vs. 15.3% for controls), other types 
of accidents (10.5% for cases vs. 15.3% for controls), gunshot wounds (8.4% for cases vs. 9.5% 
for controls), spinal related injury (4.2% for cases vs. 13.2% for controls) and followed by other 
causes (13.7% for cases vs. 9.5% for controls). The same variance was found for cases and 
controls for admitting diagnosis. An admitting diagnosis for annual evaluation accounted for 
49.5% of controls while an admitting diagnosis of decubitus ulcer accounted for 51.6% of the 
cases. Urinary tract infection (7.4% for cases vs. 6.8% for controls) and other causes followed 
with similar results for both cases and controls (Approx. 28.0%) (Tables 3 and 4).  
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Table 3. Cause of  Injury 
 Group Total 
0 Control 1 Case 
Reason for 
Injury 
1 Car Accident 
Count 53 24 77 
% within Group 27.9% 25.3% 27.0% 
2 Fall Accident 
Count 29 23 52 
% within Group 15.3% 24.2% 18.2% 
3 Motorcycle Accident 
Count 9 9 18 
% within Group 4.7% 9.5% 6.3% 
4 Other Accident 
Count 29 10 39 
% within Group 15.3% 10.5% 13.7% 
5 Gun Shot Wound 
Count 18 8 26 
% within Group 9.5% 8.4% 9.1% 
6 Spinal Related 
Count 25 4 29 
% within Group 13.2% 4.2% 10.2% 
7 Other 
Count 18 13 31 
% within Group 9.5% 13.7% 10.9% 
8 Unknown 
Count 9 4 13 
% within Group 4.7% 4.2% 4.6% 
Total 
Count 190 95 285 
% within Group 100.0% 100.0% 100.0% 
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Table 4. Admitting Diagnosis by Group 
 Group Total 
0 Control 1 Case 
Admit Dx 
1 Annual Evaluation 
Count 94 12 106 
% within Group 49.5% 12.6% 37.2% 
2 Ulcer 
Count 24 49 73 
% within Group 12.6% 51.6% 25.6% 
3 UTI 
Count 13 7 20 
% within Group 6.8% 7.4% 7.0% 
4 Other 
Count 59 27 86 
% within Group 31.1% 28.4% 30.2% 
Total 
Count 190 95 285 
% within Group 100.0% 100.0% 100.0% 
 
      As displayed in Table 5, cases (61.6%) were more likely than controls (39.2%) to have an 
ASIA score of A (complete impairment). Cases (80%) were more likely than controls (36%) to 
have a pressure ulcer on admission (Table 6). Cases (56.7%) were more likely than controls 
(30.2%) to have a positive nasal culture for MRSA on admission (Table 7). Cases (59.6%) were 
more likely than controls (32%) to have a positive nasal culture for MRSA on discharge (Table 
8). 
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Table 5. ASIA Score by Group 
 Group Total 
0 Control 1 Case 
 ASIA Score 
0 D 
Count 60 11 71 
% within Group 36.1% 12.8% 28.2% 
1 C 
Count 30 16 46 
% within Group 18.1% 18.6% 18.3% 
2 B 
Count 11 6 17 
% within Group 6.6% 7.0% 6.7% 
3 A 
Count 65 53 118 
% within Group 39.2% 61.6% 46.8% 
Total 
Count 166 86 252 
% within Group 100.0% 100.0% 100.0% 
 
Table 6. Decubitus Ulcer by Group 
 Group Total 
0 Control 1 Case 
Ulcer Decubitis 
0 No 
Count 121 19 140 
% within Group 64.0% 20.0% 49.3% 
1 Yes 
Count 68 76 144 
% within Group 36.0% 80.0% 50.7% 
Total 
Count 189 95 284 
% within Group 100.0% 100.0% 100.0% 
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Table 7. MRSA Colonization on Admission by Group 
 Group Total 
0 Control 1 Case 
MRSA Admit 
0 Negative 
Count 125 39 164 
% within Group 69.8% 43.3% 61.0% 
1 Positive 
Count 54 51 105 
% within Group 30.2% 56.7% 39.0% 
Total 
Count 179 90 269 
% within Group 100.0% 100.0% 100.0% 
 
 
Table 8. MRSA Colonization at Discharge by Group 
 
 Group Total 
0 Control 1 Case 
MRSA DC 
0 Negative 
Count 121 36 157 
% within Group 68.0% 40.4% 58.8% 
1 Positive 
Count 57 53 110 
% within Group 32.0% 59.6% 41.2% 
Total 
Count 178 89 267 
% within Group 100.0% 100.0% 100.0% 
 
     Research by Eseonu, Middleton and Eseonu (2011) found in their study that a length of 
hospital stay greater than 30 days was significantly associated  with a MRSA infection; 
therefore, the cut-points for length of hospital stay were calculated using </= 30 days and > 30 
days.  There were a greater proportion of cases showing longer lengths of stay with 88.3% 
staying > 30 days as compared to 30.5% of controls staying > 30 days (Table 9). Medical device 
use varied across groups with catheter use being 24.2% in cases and 38.9% in controls, PICC use 
11.6% in cases and 1.6% in controls, and use of a catheter and PICC simultaneously 55.8% in 
cases and 14.2% in controls (Table 10). 
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Table 9. Length-of-Stay by Group 
 
 Group Total 
0 Control 1 Case 
LOS 
0 </= 30 Days 
Count 132 11 143 
% within Group 69.5% 11.7% 50.4% 
1 > 30 Days 
Count 58 83 141 
% within Group 30.5% 88.3% 49.6% 
Total 
Count 190.00 94.00 284.00 
% within Group 100.0% 100.0% 100.0% 
 
 
 
Table 10. Device Use by Group 
 
 Group Total 
0 Control 1 Case 
 Device Use 
0 None 
Count 86 8 94 
% within Group 45.3% 8.4% 33.0% 
1 Foley 
Count 74 23 97 
% within Group 38.9% 24.2% 34.0% 
2 PICC 
Count 3 11 14 
% within Group 1.6% 11.6% 4.9% 
3 Both 
Count 27 53 80 
% within Group 14.2% 55.8% 28.1% 
Total 
Count 190 95 285 
% within Group 100.0% 100.0% 100.0% 
 
     The most common sources of infection for cases were ulcer related (31.6%) and from skin 
and soft tissue infections besides pressure ulcers (23.2%), 14.7% were Foley catheter related, 
8.4% were blood stream infections and 22.1% were from other sites/sources (Table 11). 
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Table 11. Infection Source for Cases (N=95) 
 
 Group Total 
1 Case 
Infection Source 
1 Blood 
Count 8 8 
% within Group 8.4% 8.4% 
2 SST 
Count 22 22 
% within Group 23.2% 23.2% 
3 Ulcer 
Count 30 30 
% within Group 31.6% 31.6% 
4 Catheter 
Count 14 14 
% within Group 14.7% 14.7% 
5 Other 
Count 21 21 
% within Group 22.1% 22.1% 
Total 
Count 95 95 
% within Group 100.0% 100.0% 
SST-Skin & Soft Tissue  
     
     The percentages varied in cases and controls; 67.6% of cases showed </= 89% compliance for 
hand washing for HCWs and 52.4% of controls were </= 89% compliance with hand washing 
for HCWs. Compliance also varied for the > 90% compliance group, case subjects showed 
32.6% compliance with hand washing for HCWs and HCWs compared to 47.6% for control 
subjects (Table 12). 
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Table 12. Hand Hygiene Compliance by Group 
 Group Total 
0 Control 1 Case 
Hand Hygiene 
0 </= 0.89 
Count 99 64 163 
% within Group 52.4% 67.4% 57.4% 
1 >/= 0.90 
Count 90 31 121 
% within Group 47.6% 32.6% 42.6% 
Total 
Count 189 95 284 
% within Group 100.0% 100.0% 100.0% 
 
 
Analysis of Research Questions 
 
Research Question #1 
 What is the burden of HA-MRSA in patients with a spinal cord injury? 
     A prevalence study was conducted in patients with and without spinal cord injury to 
investigate the risk of hospital acquired infection by Girard, Mazoyer, Plauchu, & Rode (2006). 
The prevalence of infection was higher in the spinal cord injury group than in those without 
injury, 23.4% and 4.8% respectively, with most infections classified as urinary tract infection. 
Urinary catheterization is very common and significantly more frequent in spinal cord injury 
patients than non-spinal injury. The spinal cord injury group had a greater number of 
comorbidities; however, the only independent predictor of infection was having an indwelling 
urinary catheter. Other common infections found in this group included skin and soft tissue, 
often related to decubitus ulcers.       
     In the current study, the most common source of infection for cases were from decubitus 
ulcers (31.6%) and from skin and soft tissue infections (besides decubitus ulcers) (23.2%), 
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14.7% were Foley catheter related, 8.4% were blood stream infections and 22.1% were from 
other sites/sources (Table 13). 
 
Table 13. Infection Source for Cases (N=95) 
 
 Group Total 
1 Case 
Infection Source 
1 Blood 
Count 8 8 
% within Group 8.4% 8.4% 
2 SST 
Count 22 22 
% within Group 23.2% 23.2% 
3 Ulcer 
Count 30 30 
% within Group 31.6% 31.6% 
4 Catheter 
Count 14 14 
% within Group 14.7% 14.7% 
5 Other 
Count 21 21 
% within Group 22.1% 22.1% 
Total 
Count 95 95 
% within Group 100.0% 100.0% 
SST-Skin & Soft Tissue  
     
Research Question #2  
 Is there an association with HA-MRSA and age, race, weight, ASIA score, decubitus ulcer, 
diabetes mellitus, anxiety/depression, hepatitis C, polysubstance abuse, alcohol use, paraplegia, 
quadriplegia, amputee, device use, MRSA colonization, length of stay, and hand hygiene 
compliance? 
     The unadjusted odds ratios (ORs) of MRSA-HAI were calculated for the following risk 
factors: Age at Admit (median split: </= 61 vs. > 61), Race (White vs. Black), Weight Status 
(Underweight or Normal: BMI < 25 vs. Overweight: BMI 25 - 29 vs. Obese: BMI > 29), ASIA 
Score (D vs. C vs. B vs. A), Decubitus Ulcer (No vs. Yes), Diabetes Mellitis (No vs. Yes), 
Anxiety-Depression (No vs. Yes), Hepatitis C (No vs. Yes), Poly-substance Abuse (None vs. 
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History vs. Current), Alcohol Abuse (None vs. History vs. Current), Paraplegia (No vs. Yes), 
Quadriplegia (No vs. Yes), Amputee (No vs. Yes), Device Used (None vs. Foley Only vs. PICC 
Only vs. Both Foley and PICC), MRSA Colonization on Admit (Negative vs. Positive), MRSA 
Colonization at Discharge (Negative vs. Positive), Length of Stay (median split: </= 30 Days vs. 
> 30 Days, and Hand Hygiene (median split: > 0.90 vs. </= 0.89). It should be noted that all 
calculations concerning Weight Status, as defined by BMI, excluded amputees since BMI is not 
relevant for amputees. 
    The unadjusted ORs (Table 14) showed that the use of a Foley catheter increased the 
univariate odds of HA-MRSA 3.3 fold, use of a PICC increased the odds 39.4 fold, and use of 
both a Foley and PICC increased the odds 21.1 fold. A hospital length-of-stay greater than 30 
days increased the univariate odds of HA-MRSA 17.1 fold. MRSA Colonization on admission 
and MRSA colonization at discharge increased the univariate odds of HA-MRSA approximately 
3 fold. Having a decubitis ulcer increased the univariate odds of HA-MRSA 7.1 fold. Having an 
ASIA score of A (Complete Impairment) increased the univariate odds of HA-MRSA 4.4 fold. 
Having an ASIA score of B or C (Incomplete Impairment) increased the univariate odds of HA-
MRSA approximately 2.9 fold. Having an amputation increased the univariate odds of HA-
MRSA 3.5 fold. Paraplegia increased the univariate odds of HA-MRSA 1.9 fold. Hand hygiene 
compliance for HCWs of </= 0.89 increased the univariate odds of HA-MRSA 1.88 fold. 
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Table 14. Unadjusted Odds Ratios for MRSA Hospital Acquired Infection (n = 190 Controls; n = 
95 Cases) 
Variable1 Categories 0 Control 1 Case Odds Ratio P-Value 
Age at Admit 
0 </= 61 101 (52.3%) 48 (51.6%)   
1 > 61 89 (46.8%) 45 (48.4%) 1.064 0.807 
Race 
0 White 107 (59.1%) 46 (52.3%)   
1 Black 74 (40.9%) 42 (47.7%) 1.320 0.288 
Weight 
Status 
(Amputees 
Excluded) 
0 Underweight or 
Normal (BMI < 25) 65 (38.7%) 30 (39.5%) 
  
1 Overweight  
(BMI 25 - 29) 53 (31.5%) 29 (38.2%) 1.186 0.594 
2 Obese (BMI > 29) 50 (29.8%) 17 (22.4%) 0.737 0.392 
ASIA Score 
0 D 60 (36.1%) 11 (12.8%)   
1 C 30 (18.1%) 16 (18.6%) 2.909 0.018 
2 B 11 (6.6%) 6 (7.0%) 2.975 0.071 
3 A 65 (39.2%) 53 (61.6%) 4.448 < 0.001 
Decubitis 
Ulcer 
0 No 121 (64.0%) 19 (20.0%)   
1 Yes 68 (36.0%) 76 (80.0%) 7.118 < 0.001 
Diabetes 
Mellitis 
0 No 141 (74.6%) 72 (75.8%)   
1 Yes 48 (25.4%) 23 (24.2%) 0.938 0.828 
Anxiety-
Depression 
0 No 132 (69.5%) 74 (77.9%)   
1 Yes 58 (30.5%) 21 (22.1%) 0.646 0.136 
Hepatitis C 
0 No 168 (88.4%) 83 (87.4%)   
1 Yes 22 (11.6%) 12 (12.6%) 1.104 0.796 
Poly-
substance 
Abuse 
0 None 148 (82.2%) 74 (82.2%)   
1 History 22 (12.2%) 11 (12.2%) 1.000 1.000 
2 Current 10 (5.6%) 5 (5.6%) 1.000 1.000 
Alcohol Use 
0 None 131 (72.4%) 64 (72.7%)   
1 History 28 (15.5%) 11 (12.5%) 0.804 0.573 
2 Current 22 (12.2%) 13 (14.8%) 1.210 0.618 
Paraplegia 
0 No 115 (64.6%) 45 (48.9%)   
1 Yes 63 (35.4%) 47 (51.1%) 1.907 0.013 
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Quadriplegia 0 No 91 (50.0%) 55 (59.8%)   
1 Yes 91 (50.0%) 37 (40.2%) 0.673 0.126 
Amputee 
0 No 179 (94.2%) 78 (82.1%)   
1 Yes 11 (5.8%) 17 (17.9%) 3.547 0.002 
Device Used 
0 None 86 (45.3%) 8 (8.4%)   
1 Foley Only 74 (38.9%) 23 (24.2%) 3.341 < 0.001 
2 PICC Only 3 (1.6%) 11 (11.6%) 39.417 < 0.001 
3 Both Foley and PICC 27 (14.2%) 53 (55.8%) 21.102 < 0.001 
MRSA 
Colonization 
on Admit 
0 Negative 125 (69.8%) 39 (43.3%)   
1 Positive 54 (30.2%) 51 (56.7%) 3.027 < 0.001 
MRSA 
Colonization 
at Discharge 
0 Negative 121 (68.0%) 36 (40.4%)   
1 Positive 57 (32.0%) 53 (59.6%) 3.125 < 0.001 
Length of 
Stay 
0 </= 30 Days 132 (69.5%) 11 (11.7%)   
1 > 30 Days 58 (30.5%) 83 (88.3%) 17.172 < 0.001 
Hand 
Hygiene 
0 >/= 0.90 90 (47.6%) 31 (32.6%)   
1 </= 0.89 99 (52.4%) 64 (67.6%) 1.88 0.017 
1Note: The reference category for each variable is the first-listed category for that variable. 
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Research Question #3  
What evidence from this study will validate previous studies on HA-MRSA risk factors?  
     Assessment of risk factors for HA-MRSA for spinal cord injury patients in this study found 
that colonization, device use, paralysis, ASIA score, amputation, decubitus ulcer, length of 
hospital stay and hand hygiene compliance were each associated with acquiring a HA-MRSA 
infection. These risk factors are similar to those described in previous studies in other  hospital 
populations besides those in a spinal cord injury unit.  
    In addition to confirming the risk factors, this study also confirms that current efforts targeting 
the reduction of MRSA in the SCIU at the VAMC are necessary due to the associated risk 
factors; in particular, colonization, the number of patients admitted with decubitus ulcers and 
device use. The study also affirms current assumptions about this population having special 
medical needs and being at high risk for MRSA disease.  
     Lastly, the analysis of the data also confirms the long standing assertion that hand hygiene is 
correlated with infection and transmission of MRSA. 
Research Question #4  
 What new information on MRSA will emerge from this study?  
     The current study was able to provide a descriptive analysis to this hospital for patients within 
a dedicated spinal cord injury unit, address specific risk factors associated with HA-MRSA and 
the burden of infection. This has not been done before at this hospital for this particular 
population and providing baseline characteristics to the hospital is important when making 
decisions on designing and implementing an effective infection control program. The 
information from this research can be used as an educational tool for patients and family and can 
provide teaching points regarding contact precautions, colonization, and the importance for hand 
EPIDEMIOLOGY of HA-MRSA 
  
 
64 
 
washing compliance. This study affirms that current efforts targeting the reduction of MRSA in 
the SCIU at the VAMC, such as the MRSA bundle, are readily needed due to the associated risk 
factors and characteristics of the population admitted to the spinal cord injury unit. 
     Due to limited information on this patient population, understanding risk factors and the 
burden of MRSA in the past were generalized from data on patients in the acute care setting or 
the ICU. Quality improvement processes should not always be a "one size fits all" approach and 
patient populations, the organisms and site of infection are often unique to the hospital and its 
environment and community. The current study found 80% of the case subjects were admitted 
with decubitus ulcers, and this was the most common source of HA-MRSA infection. Some 
studies have shown catheter associated urinary tract infections as the primary source of infection 
in spinal cord injury patients due to the increased use of Foley catheters; however, catheter 
associated infections were next to last as a source of infection in the current study. 
      The current study found that risk factors associated with HA-MRSA are similar to patients in 
hospital populations that have been previously studied; however, univariate statistics from the 
study provided a rich description of the population which will give infection control a better 
understanding of their patient population being admitted. This information will aid in 
strengthening the design of the infection control program currently in place or allow for the 
tailoring of a needed intervention to the specific needs of the patients in the spinal cord injury 
unit.  
     Additionally, the study also provided the basis for future analysis and to further contribute to 
the knowledge base by identifying the need to study interactions/effect modifiers within the 
potential risk factors previously described (e.g., age, race or device use). 
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CHAPTER 5 
SUMMARY, DISCUSSION, AND CONCLUSION 
Summary  
     The purpose of this case-control study was to gain a better understanding of the burden of 
HA-MRSA and to assess risk factors associated with the acquisition and transmission of HA-
MRSA in a dedicated spinal cord injury unit (SCIU) at a Veterans Affairs Medical Center. The 
case-control study was also conducted to see if new information would emerge on HA-MRSA 
infections and validate current research. 
Research Question #1: What is the burden of HA-MRSA in patients with a spinal cord injury? 
          Patients with spinal cord injuries or disorders due to trauma, spinal stenosis, vertebral 
osteomyelitis, and other causes often have a neurogenic bowel and bladder, decubitus ulcers, 
frequent hospitalizations, as well as having experienced numerous surgeries. Decubitus ulcers 
(pressure ulcers) often do not resolve readily and may become chronic wounds requiring 
frequent dressing changes. Also, patients with a neurogenic bowel and bladder often require 
digital stimulation of the bowel and urinary catheterization (Evans et al., 2012). Each of these 
practices requires frequent contact with contaminated body fluids by HCWs and may lead to the 
development of a HAI.   
     During fiscal years 2008-2011, 95 cases of MRSA were identified by the Infection Control 
and Epidemiology department at the VAMC with the average age of the cohort on admission 
being 59.81 years, and with a greater proportion of males vs. females. The cohort was 
predominately white (52.3% cases vs. 59.1% controls). 
     Case infections were identified through the application of the CDC/NHSN surveillance 
definitions by specific definition. Infections were divided into the following categories: (1) 
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blood; (2) skin and soft tissue (SST) (cellulitis, soft tissue/wound infection); (3) skin and soft 
tissue (decubitus ulcer); (4) catheter associated urinary tract infection, and; (5) other causes of 
infection.   
     Case-control analysis of the data showed that having a decubitus ulcer upon admission 
increased the univariate odds of HA-MRSA 7.1 fold (p < 0.001). Patients with decubitus ulcers 
upon admission comprised 80% of the case subjects and of the 95 cases identified with HA-
MRSA, 31.6% subsequently acquired an infection from a decubitus ulcer site. Decubitus ulcers 
were located in areas such as the sacral, ischial, trochanter, femur, and hip areas. Skin and soft 
tissue infections were the second most prevalent infection comprising 23.2% of the case subjects. 
Skin and soft tissue infections, causing cellulitis, were cultured from areas such as the shoulder, 
inguinal region, abdomen, ankle, leg, and arm. Of the 95 MRSA cases identified, 24.2% had 
indwelling Foley catheters increasing the likelihood of a HA-MRSA infection by 3.341 fold; and 
subsequently, almost 15% of those patients developed a catheter associated urinary tract 
infection with MRSA. Other sources such as bone-joint infection, deep tissue, lower respiratory 
and ventilator associated infections, and epidural abscess accounted for 22.1% of the HA-MRSA 
infections. These types of infections were collapsed into one category due to sparse numbers of 
each of these in the cases. And, lastly, blood stream infections accounted for 8.4% of the HA-
MRSA infections and were defined as either a lab confirmed blood stream infection or associated 
with a central line. In this study, a patient with a central line or PICC had a 39.42-fold increase 
for a HA-MRSA infection. 
Research Question #2: Is there an association with HA-MRSA and age, race, weight, ASIA 
score, decubitus ulcer, diabetes mellitus, anxiety/depression, hepatitis C, polysubstance abuse, 
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alcohol use, paraplegia, quadriplegia, amputee, device use, MRSA colonization, length of stay, 
and hand hygiene compliance? 
      The average age of the cohort on admission was 59.81 years with no significant difference 
occurring between cases and controls. The cohort was predominately white (52.3% cases vs. 
59.1% controls), had a mean length of stay of 83.2 days and a mean hand-hygiene compliance of 
65% for HCWs. The majority of the case subjects had an admitting diagnosis of decubitus ulcer 
(51.6%) with the majority of controls having an admitting diagnosis of annual evaluation 
(49.5%). Decubitus ulcer was the most common infection identified in the case subjects 
comprising 51.6% of the group, other skin and soft tissue infections (not including decubitus 
ulcers) accounted for 23.2% of the infections, Foley catheter followed with 14.7%, blood stream 
infections 8.4%, and other causes of infection were 22.1%. 
     Case-control analysis of the data showed that having a decubitus ulcer upon admission 
increased the univariate odds of HA-MRSA 7.1 fold (p < 0.001). Patients with decubitus ulcers 
comprised 80% of the case subjects, and 36% of the control subjects. A hospital length-of-stay 
greater than 30 days increased the univariate odds of HA-MRSA 17.1 fold (p < 0.001). Cases 
showed a greater percentage at 88.3% vs. 30.5% in control subjects. The unadjusted odds ratio 
showed that the use of a Foley catheter increased the univariate odds of HA-MRSA 3.3 fold (p < 
0.001), use of a PICC line increased the odds 39.4 fold, (p < 0.001) and use of both a Foley 
catheter and PICC line increased the odds 21.1 fold (p < 0.001). Case subjects showed a Foley 
catheter use of 24.2% vs. 38.9% in control subjects, PICC line use was 11.6% in cases vs. 1.6% 
in controls, and use of a Foley catheter and PICC line together comprised 55.8% of case subjects 
and 14.2% of control subjects.  
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     An ASIA score of A (complete impairment) increased the univariate odds of HA-MRSA 4.4 
fold and having an ASIA score of B or C (incomplete impairment) increased the univariate odds 
approximately 2.9 fold. An ASIA score of A accounted for 61.6% of case subjects and an ASIA 
score of B or C accounted for approximately 6.6% and 18.0% respectively. 
     Other factors associated with a significantly increased univariate odds (p < 0.05) for HA-
MRSA were colonization on admission (OR: 3.0) and discharge (OR: 3.1), having an amputation 
(OR: 3.5), being paraplegic (OR: 1.9), and having a HCW with a hand-hygiene compliance of 
</= 0.89 (OR: 1.88).  
    Comorbidities can play a central role in the acquisition of a hospital acquired infection 
resulting in longer hospital stays, increased cost to the patient and often debilitating effects, if not 
death. Older adults are at higher risk because of the presence of multiple comorbid conditions, 
functional impairment and a reduced immune response. Several comorbidities included in the 
study but showing no significance for increased odds of HA-MRSA included anxiety/depression, 
having diabetes mellitus, hepatitis C, and poly-substance abuse.  
     A number of studies have shown a strong association with age and infection; however, in the 
current study age was not significantly associated with infection. Kuehnert et al. (2005), using 
discharge data, reported MRSA rates for septicemia, pneumonia, and other infections increased 
with patient’s age with most diagnoses occurring in persons > 65 years of age. The study also 
reported that the overall MRSA rate increased with patient age. Klevens et al. (2008) also found 
an increase in MRSA infections among older adults aged > 65 years and in hospitals with < 200 
beds. Another study, by Payman & Delorme, (2008) in a medical center reported a significant 
increase in the incidence of MRSA among young patients 6-25 years of age, as well as patients 
45-50, and the elderly, 86-90. In the current study, 48% of HA-MRSA infections occurring in the 
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case subjects were diagnosed in patients > 61 years of age and unlike the previous studies, 
slightly over half (52%) of HA-MRSA infections in the case subjects were diagnosed at </= 61 
years of age. The difference in age associated infections from the general hospital population 
when compared to the current population under study may be related to the multiple comorbities 
associated within the spinal cord injury population. 
Discussion of Major Findings 
          The theory informing this research, The Theory of Planned Behavior, was previously 
described and provided the reader with an understanding of the behavior associated with the 
HCW's intent and their adherence, or not, to hand hygiene recommendations and compliance. 
Proper hand hygiene compliance has been cited in the literature as one of the most important 
functions a HCW can perform to prevent the spread of infection. Due to the nature of the injury 
in spinal cord patients most have had frequent hospitalizations and surgeries, many are colonized 
with MRSA and have multiple decubitus ulcers, and often require use of multiple devices; each 
predisposing the patient to infection. Each of these factors lead to frequent contact by HCWs and 
unless adherence to hand hygiene compliance is maintained, infection may occur.  
     The purpose of this case-control study was to assess risk factors contributing to HA-MRSA 
and gain a better understanding of the burden of HA-MRSA in patients with spinal cord injuries. 
The case-control study was also conducted to see if new information would be found on HA-
MRSA infections and validate or refute current research on the topic for patients in a dedicated 
spinal cord injury unit at a Veterans Affairs Medical Center. 
     This case-control study was also undertaken to better understand the risk factors associated 
with MRSA in this population and setting due to limited information and to support needed 
recommendations and efforts currently being used to reduce infections at the VAMC. Such 
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efforts include: 1) PCR testing for patients admitted and transferred to the spinal cord injury unit, 
2) contact isolation for patients colonized with MRSA and with an ongoing MRSA infection, 3) 
increased hand washing awareness through education for HCWs and family members, and; 4) 
use of gown and gloves for all having direct contact with patients colonized and infected with 
MRSA. This study provides evidence to aid in the design of an effective infection control 
program tailored to the specific needs of patients in the spinal cord injury unit. After analyzing a 
number of variables that are well documented in the literature as risk factors in this patient 
population, this study found device use, colonization with MRSA on admission, hospital length-
of-stay over 30 days, hand hygiene compliance, amputation, decubitus ulcer, ASIA score and 
paraplegia as being significantly associated as risk factors for HA-MRSA.  
     Invasive devices pose the greatest threat to patients for serious infections. A case-control 
study by Kaye, et al. (2011) found indwelling central venous catheters to be a primary cause for 
HA-MRSA bloodstream infections. In the current study, of the 95 case subjects with MRSA, 
11.6% had a PICC inserted upon admission increasing the odds of HA-MRSA 39.4-fold.  In 
contrast, the study by Kaye, et al. (2011) found the presence of a central line on admission 
almost doubled the risk factor for a blood stream infection. Both studies indicate a patient is at 
high risk for infection; however, spinal cord injury patients may be at a greater risk because of 
being colonized with MRSA, the presence of multiple comorbidities and frequent contact by 
HCWs.  
     The same study by Kaye, et al. (2011) and another study by Girard, Mazoyer, Plauchu, and 
Rode (2006) found indwelling Foley catheter use an independent predictor for infection. The 
current study found indwelling Foley catheter use increased the odds of HA-MRSA 3.3-fold. The 
current research also found if both a Foley catheter and PICC line were both being used 
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simultaneously, the odds increased 21.1-fold. Simultaneous use of these devices accounted for 
55.8% of the MRSA case subjects vs. 14.2% of the control subjects. Due to the nature of the 
injury sustained by this population of patients, many require use of an indwelling Foley catheter 
as well as the use of the PICC line simultaneously for long term antibiotic therapy due to 
infection or other therapeutic treatment. Although, 24.2% of cases had an indwelling Foley 
catheter, and 55.8% had both a indwelling Foley and PICC line, catheter associated urinary HA-
MRSA were not the primary or secondary source of HA-MRSA infections.  
     Patients who remain in hospitals for extended lengths of time may be exposed to longer 
antimicrobial use, invasive procedures, and greater contact with healthcare workers. Past studies 
have suggested that each of these healthcare characteristics may increase a patient's chance to 
acquire MRSA (Santos, et al., 2010; WHO, 2009). Eseonu, Middleton, & Eseonu (2011) 
conducted a study in an orthopedic trauma center and found hospital length-of-stay greater than 
30 days to be significantly associated with a HAI. Similarly, a hospital length-of-stay greater 
than 30 days in the current study also demonstrated a significant association with a 17.2-fold 
increase in the odds for acquiring HA-MRSA. In the current study, a large proportion of the case 
subjects, 88.3%, remained in the hospital greater than 30 days when compared to 30.5% of the 
control subjects. A prospective study by Kappel and colleagues (2008) in patients with spinal 
cord injuries found a mean duration of stay of 147 days for patients with MRSA infection 
compared to 63 days for MRSA negative patients. The study associated the longer 
hospitalization time due to an interruption in treatment and rehabilitation because of isolation 
due to the infection and also the high percentage of patients admitted with decubitus ulcers. The 
study also found that MRSA positive patients had a greater frequency of ulcers on admission 
when compared to MRSA negative patients. The same was true in the current study.  
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     The high-risk nature of the spinal cord injury patient, how sick the patient was upon 
admission, when the infection occurred during the patients stay, decubitus ulcers on admission,  
surgery, and the number of comorbidities present are considered possible reasons for the 
differences in the length-of-stay. Estimating a true value for hospital length of stay created a 
statistical challenge in this study in that MRSA infection may have increased the length of stay 
and simultaneously may have increased the chance of infection (Barnett et al., 2009). Due to the 
sparse sample size in the study, confounders and effect-modifiers that may have been associated 
with increasing hospital length of stay were not considered in the current analysis and will 
provide the basis for a future study. 
     Colonization and infection rates vary by setting; such as the type of health-care facility and 
the population being studied (Davis, Stewart, Crouch, Florez, & Hospenthal, 2004). Recently 
published studies have arrived at varying conclusions regarding colonization with MRSA and the 
association with subsequent MRSA infections. Safder & Bradley (2008) found in their study that 
MRSA nasal colonization increased the risk for subsequent infections four times among carriers, 
particularly for patients in the ICU. Results from the current study found similar results in that 
colonization with MRSA on admission would likely increase the risk for infection three fold 
among carriers. Univariate statistics showed that over 56.7% of the case subjects were colonized 
with MRSA on admission while only 30.2% of control subjects were colonized. By contrast, 
Sarikonda, et al. (2010) and Klevens, et al. (2009) did not find colonization to be a strong 
predictor for subsequent occurrence of infection. The increased colonization for case subjects 
may be due to increased exposure to the hospital environment from frequent hospitalizations and 
increased contact with HCWs. 
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     Indeed, hand hygiene is the single most effective and inexpensive way to reduce or eliminate 
infections from occurring; yet, in most hospitals, the compliance rate among HCWs rarely 
exceeds 50% (Gilbert, Stafford, Crosby, Fleming, & Gaynes, 2010). A study was conducted 
among ICUs in hospitals that were members of the National Nosocomial Infection Surveillance 
System. The study was initiated following the publication of the CDC Hand Hygiene Guide. 
Forty hospitals were recruited and following the study period hand hygiene rates for HCWs were 
low, resulting in a mean compliance of 56.6%. (Larson, Quiros, & Lin, 2007).  
     Another study, conducted by Gilbert and colleagues (2010) at a VAMC in Atlanta, GA found 
similar results for hand hygiene compliance among HCWs as the previous study. The study was 
conducted in the medical and surgical intensive care units using a trained observer to collect 
hand hygiene compliance by the type of room (contact precaution vs. noncontact precautions). 
The overall hand hygiene compliance for the surgical intensive care unit was 50.7% in contact 
precaution rooms vs. 51.7% compliance in the noncontact precaution rooms. The medical 
intensive care unit had similar hand hygiene compliance rates, 45.1% in contact precaution 
rooms vs. 50.8% in noncontact precaution rooms. One third of patients hospitalized at the 
Atlanta VA were on contact precautions, and approximately half of the patients on contact 
precautions were placed under these precautions because of the implementation of the MRSA 
bundle.  
     To match the VA's criteria, the cut point used for hand hygiene compliance was either </=.89 
or >/=.90.The current analysis showed that having a hand hygiene compliance of </= 0.89 among 
HCWs increased the odds for infection 1.88-fold. Hand hygiene compliance for HCWs caring 
for case and control subjects varied whereas 67.6% of HCWs caring for MRSA case subjects 
demonstrated </= 89% compliance and 52.4% compliance for control subjects. Compliance also 
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varied for HCWs in the >/= 90% compliance group, whereas HCWs caring for MRSA case 
subjects showed 32.6% compliance and 47.6% compliance in the control subjects.  
      Collection of hand hygiene data for HCWs in the Spinal Cord Injury Unit was observational 
and used both trained staff and independent monitors. The data were reported quarterly to the 
Infection Control Department as part of routine surveillance. A minimum of ten opportunities to 
wash hands or use alcohol-based hand rub was observed by each department/unit and reported as 
a percentage for the quarter.  
     Providing the unit with a staff monitor may correlate with an increased exposure of the unit to 
hand hygiene education since it involves educating both the staff monitor performing the hand 
hygiene observations and the manager on the unit who interprets the results. The act of 
performing the hand hygiene observation may also create a Hawthorne effect, that is, artificially 
improving hand hygiene temporarily.  
     Hand hygiene compliance is unlikely to be homogeneous across all shifts on all days of the 
week, and the staff performing the observation may not be sensitive enough to indicate small 
aberrations. However, for units where the staff monitor is consistently present and used, it may 
best correlate with the overall culture of safety, receipt of education and interest in performance 
improvement. Additionally, more accurate data about hand hygiene compliance may be provided 
using the staff monitor because of reasons mentioned previously. 
     The other mechanism to track compliance is the independent monitor. This monitor often 
provides more objective data with a higher volume of observations per period; however, this 
method may also be subject to the Hawthorne effect. 
     Due to the Hawthorne effect, when HCWs know other people are observing them they 
become more conscious and vigilant with hand washing procedures and compliance. This may 
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have inflated the hand washing compliance and data reported to the Infection Control 
Department in the quarterly report during the period of study. 
     Decubitus ulcer was significantly associated as a risk factor for HA-MRSA with a 7.18-fold 
increased likelihood for infection. This was the most common infection site identified for this 
population of patients with 80% of the case patients admitted to the spinal cord injury unit with a 
decubitus ulcer. Yates, et al. (2009) conducted a prospective study in patients with diabetes-
related foot infections and found that wound chronicity independently predisposed patients to 
MRSA infections. A prevalence study was conducted in patients with and without spinal cord 
injury to investigate the risk of hospital acquired infection by Girard, Mazoyer, Plauchu, & Rode 
(2006). The prevalence of infection was higher in the spinal cord injury group than in those 
without injury, 23.4% and 4.8% respectively. And, unlike the population of patients in the 
current study, most infections were classified as urinary tract infection. Although the prevalence 
of infection was higher in the spinal cord injury group, differences may occur in the prevalence 
based on type and site of infection emphasizing the importance for understanding a patient 
population in individual hospital settings. 
     Through the identification of risk factors for MRSA, strategies may be put in place to prevent 
the spread of resistant organisms with an emphasis on early detection of at-risk patients and use 
of aggressive hand hygiene compliance and isolation. 
     Several other patient characteristics found to predispose a patient to HA-MRSA in this study 
included having an amputation (OR: 3.54), having an ASIA score A (OR: 4.48) (complete 
impairment) and paraplegia (OR: 1.9). These characteristics are related to a decrease in a 
patient’s ability to walk, bathe, eat, and perform normal bathroom functions. These limitations 
with daily functional activities require frequent patient contact by HCWs and may predispose 
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patients to MRSA infection and colonization. A nested case-control study by Chen et al. (2011) 
with elderly patients found that poor functional status and requiring assistance with three or more 
activities an independent risk factor for MRSA surgical site infections (OR:2.73). Another study, 
conducted by Kaye et al. (2011) found an association between urinary incontinence, an important 
aspect of functional status in patients with spinal cord injury, and MRSA blood stream infection. 
This increased risk of infection may have been related to a patient’s severity of illness, a greater 
frequency of contact by HCWs, a greater likelihood of having an indwelling catheter, and 
possibly related to poorer hygiene than patients without urinary incontinence. These patient 
characteristics are associated with immobility and poor functional status often requiring 
increased contact by HCWs and family members. 
     Study Strengths  
      One of the major strengths of this study is that it is the first attempt to describe the 
population admitted to a dedicated spinal cord injury unit at this VAMC providing new 
information to the hospital infection control department. Also, because of a lack of current 
information in general on this population regarding the burden of MRSA and the associated risk 
factors for the disease, the analysis provided current information for use at this hospital and the 
data may be of value to other VAMCs for benchmarking within spinal cord units. This analysis 
will be helpful to the Infection Control Department in tailoring their interventions, strengthening 
existing measures, and to justify a need for increased funding to promote preventive efforts to 
reduce HAIs, such as the MRSA bundle. Education can also be tailored for patients, medical 
personnel, and family based on information obtained from this study such as characteristics of 
the population and risk factors specifically associated with this population for HA-MRSA. 
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     The study also identified a need to further explore interactions and effect modifiers within the 
potential risk factors such as ASIA score and decubitus ulcer and PICC line and Foley catheter. 
     Study Limitations 
     There were several limitations identified in this study primarily associated with having a 
sparse sample size and missing data. Data were not available for MRSA cases for fiscal year 
2008 and were not included in the study. The number of cases present in that year may have 
improved the statistical power of the analysis. Data were missing for multiple quarters on hand 
hygiene compliance which are observational and self-reported and may have contributed to study 
bias. 
     Additionally, the VAMC is largely comprised of male patients. No females were included in 
the study due to having only one female case identified over the period under study. Due to the 
use of this VAMC population, it is not fully representative of the overall U.S. population given 
that it is mostly male, over 50 years of age and at high risk for infection.  
     Another major limitation of the study was a sparse data set found in case subjects. This 
resulted in the removal of "other" races from the study. Additionally, the sparse data set did not 
allow for further analysis to be conducted for interactions/effect modifiers within the potential 
risk factors. Therefore, the odds ratio for using a PICC line and a Foley catheter simultaneously 
showed reduced odds for acquiring HA-MRSA when compared to using a PICC line or Foley 
catheter alone. 
    Suggestions for Future Research 
     Additional research using a larger sample size for analysis of interactions and effect modifiers 
within the potential risk factors may prove to show beneficial data. Also, the current study 
explored healthcare associated risk factors for HA-MRSA; however, less is known about 
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socioeconomic factors, as well as how living in a rural vs. an urban area may contribute to 
MRSA infection and colonization. Also, comparing patients in the acute care setting to the spinal 
cord injury population may provide interesting results. 
     Each of these ideas are important areas for further study in this population of patients and for 
public health. 
   Implications for Public Health and the VAMC 
     Considered an emerging issue and a threat to public health, Healthy People 2020 created a 
new goal, “...Prevent, reduce, and ultimately eliminate healthcare-associated infections (HAIs) 
(US Department of Health and Human Services, 2010). Reflecting the commitment to reducing 
healthcare-associated infections, two supporting objectives were created by Healthy People 
2020: (HAI-1) reduce healthcare-associated infections by reducing central line associated 
bloodstream infections; and (HAI-2) to reduce invasive healthcare-associated methicillin-
resistant Staphylococcus aureus infections by 75%  nationwide (US Department of Health and 
Human Services, 2010). The basis of this study was to gain a better understanding of risk factors 
associated with HA-MRSA infection and address the burden of MRSA. The case-control study 
was also conducted to see if new information would be found or refute current literature on HA-
MRSA. This information would be used to aid in the reduction and eventually the elimination of 
HA-MRSA within the VAMC. 
      The results of this research can be used to better inform physicians, healthcare workers, 
patients, and infection control practitioners about HA-MRSA infection and transmission. 
Providing a descriptive analysis to this hospital for patients with a spinal cord injury, associated 
risk factors for HA-MRSA and the burden of infection is important when designing and 
implementing an effective infection control program. 
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     The VAMC had appreciated the preponderance of MRSA infections in decubitus ulcers, and 
had implemented a screening program on admission to identify wounds already infected or 
colonized with MRSA on admission in 2012. From the current research, the VAMC had not 
appreciated the quantity of HA-MRSA for skin and soft tissue (SSTIs) infections. The VAMC 
will take a closer look at what these SSTIs are and identify if there are ways to intervene. For 
example, if they are surgical site infections, perhaps bolstering the pre-operative regimen to be 
more efficient against MRSA will help to decrease these types of infections. If the infections are 
associated with central line sites, perhaps line placement and maintenance will be reviewed. 
Also, if the skin and soft tissue infections are related to boils or furuncles and in those attending 
the physical therapy gym, the equipment may need more thorough cleaning. 
     Device use and length of stay have often been associated with increased infection rates; 
however, it is interesting that the ASIA score was also associated with an increased risk for HA-
MRSA. Perhaps the cohorting methodology, which already gives preference to neutropenic or 
immunocompromised patients for private rooms should consider the ASIA score as well to 
reduce the exposure of these patients to other patients with MRSA.  
    Also, due to the number of HA-MRSA infections in this population, the VAMC will look to 
focus interventions back on patients with decubiti and not as much on those with Foley catheters, 
although important. A multivariate analysis would also be informative for a future study by 
exploring potential confounders within the potential risk factors. 
     The evidence based information from this research can also be used as an educational tool for 
patients and family and can provide teaching points regarding contact precautions, colonization, 
and the importance for hand washing compliance. The VAMC certainly recognizes the need to 
change the culture to increase the self-efficacy of the patients and the staff to believe they can 
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achieve hand hygiene compliance. And although awkward, the VAMC encourage their patients 
to remind staff to wash their hands and will continue to do so. In the future, and as nursing 
competencies become more integrated into their evaluation system, it is hopeful that hand 
hygiene becomes a competency that their managers evaluate them on. There is currently no 
administrative oversight for hand hygiene compliance and if the individual nurse managers 
address it, it is of their own volition. Once consistent hand hygiene becomes the subjective norm 
and there is peer pressure, managerial pressure, and patient advocacy pressure to be consistent in 
the discipline of hand hygiene, then the hand hygiene results should improve. The current 
method for achieving cultural change is through education. This research will allow the VAMC 
to educate staff and patients using their own data, rather than national studies to drive the 
importance of their hand hygiene compliance. 
     The results found in this study also support the importance of the prevention strategies 
currently being used at the VAMC in this population and already proven effective in acute care 
or long term care. It supports the need for adhering to guidelines for each of the components of 
the  MRSA bundle because of such risk factors as colonization and decubitus ulcers, both 
associated with HA-MRSA in this at-risk population.  
     Adhering to guidelines can be expensive and time consuming for healthcare workers. 
Information from this study may also provide needed justification for allocation of resources and 
funding to continue, strengthen, or add prevention strategies and improve quality processes as 
mentioned previously. 
      Following these guidelines and tailoring prevention strategies based on data relative to the 
spinal cord injury population allow this hospital to reflect their commitment towards the 
reduction of HA-MRSA infections and can lead to a reduction in hospital and patient costs, a 
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reduction in readmission rates, morbidity and mortality. Each is an important aspect in public 
health.                                                  
                                                       Conclusion 
     The purpose of this case-control study was to assess risk factors contributing to HA-MRSA 
and gain a better understanding of the burden of HA-MRSA in patients with spinal cord injuries. 
The case-control study was also conducted to see if new information would be found on HA-
MRSA infections and validate or refute current research on the topic for patients in a dedicated 
spinal cord injury unit at a Veterans Affairs Medical Center.  
     In 2007 the VAMC implemented a MRSA bundle consisting of universal nasal swabbing for 
colonization of MRSA, contact precautions for all colonized patients with MRSA, increased 
hand hygiene washing to include education and monitors, and a change in institutional culture in 
that infection control became the responsibility of everyone who had contact with patients.     
The success for reduction in HA-MRSA infections and transmission relies heavily on HCWs 
following proper hand washing guidelines recommended by the CDC with each of the 
components of the prevention "bundle" working synergistically. Evidence suggests that 
interventions that are theory driven are more effective than those without a theoretical 
background (Glanz & Bishop, 2010). The theory informing this research, the TRA/TPB, helped 
explain the behavior and relationship between the HCWs intent and their adherence to hand 
hygiene recommendations, in particular, the HCWs perceived control. To achieve greater hand 
washing compliance the VAMC hopes to change the culture in the hospital and promote self-
efficacy for staff. This will be achieved through education and use of the data from this research 
to drive home the importance of their hand hygiene compliance.  
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      Infection control strategies should be tailored to a specific population as infection prevention 
and quality improvement processes should not be  a "one size fits all" approach. The current 
study was able to provide a descriptive analysis to this hospital for patients within a dedicated 
spinal cord injury unit, address specific risk factors associated with HA-MRSA, and address the 
burden of HA-MRSA. This study confirms that current efforts targeting the reduction of MRSA 
in the SCIU at the VAMC are justified in their use because of such risk factors as colonization 
and the number of patients with decubitus ulcers on admissions. The study also affirms current 
assumptions about this population being at risk for MRSA disease. And, although not 
generalizable in most hospital settings, this study may be of value to other VA hospitals with 
spinal cord injury units and rehabilitation settings. 
      Improving the quality of patient care through surveillance and prevention activities is a 
valuable asset provided by infection control programs. Therefore, understanding the patient 
population in the hospital setting is valuable in providing information which can help strengthen 
the overall program. The current research will help the VAMC justify aggressive infection 
control strategies, such as hand washing, cohorting of patients based on their ASIA score, and 
adjusting the focus of interventions on patients with decubiti and not as much on those with 
Foley catheters.  
     Over the last ten years a greater emphasis has been placed on reducing such adverse events as 
HAIs caused by MRSA. Proposed guidelines, such as the MRSA bundle can aid infection control 
programs in reducing infection and transmission by MRSA, deaths, and the cost related to each 
of these. The current research will allow the VAMC to educate staff using their own data, not 
national studies to drive home the importance of their hand hygiene. The data from this study 
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will also provide information to help refocus interventions in other areas. Future research efforts 
may focus studying other modifiable risk factors  that predict HA-MRSA infection. 
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APPENDICES 
A. Protocol: Epidemiology of Hospital Acquired Methicillin-Resistant Staphylococcus  
aureus in a Veterans Affairs Medical Center Spinal Cord Injury Unit: Fiscal Years 2008- 
2011 
 
Chart Reviewer: Rebecca B. Stone  
Date of Review: _________________ 
 
Data Capture Form 
 
Patient  ID 
 
 
Case 
 
Control #1 
 
Control #2 
Birth Year  
 
  
Race  
 
  
Gender  
 
  
Ethnicity  
 
  
Height  
 
  
Weight  
 
  
BMI (Calculated) 
 
   
Antibiotics:  Y/N (If yes, 
list) 
 
   
Wound Consult: Y/N  
 
  
Infection Source/Type 
 
 
 
 
   
CA-MRSA on Admission: 
Y/N 
   
CA-MRSA on Discharge: 
Y/N 
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Device Use: (If yes, 
type.e.g. central line, etc.) 
 
 
   
Cause of Injury:  
 
  
ASIA Score 
 
   
Admission Date 
 
   
Area of Service  
 
  
Admission Diagnosis  
 
  
Cause of death/underlying 
cause of death 
   
Discharge Date    
Length of Stay    
Neurogenic Bladder  
 
  
Neurogenic Bowel  
 
  
Sexual Dys. 2ndary  
 
  
Diabetes Mellitus II  
 
  
Hypertension  
 
  
Chronic Neuropathic Pain  
 
  
Anxiety/Depression  
 
  
Annual Spinal Cord Eval.  
 
  
Hepatitis  
 
  
HIV  
 
  
Decubitus Site/ Stage  
 
  
Hemorrhoids  
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AKA  
 
  
Cholecystitis  
 
  
Cholelithiasis  
 
  
Hypotension  
 
  
Spasms  
 
  
Osteomyelitis  
 
  
Anxiety/Depression/PTSD  
 
  
Smoking History  
 
  
Drug History  
 
  
Alcohol History  
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B. MRSA Validation Tool for Spinal Cord Injury Patients Age 18 & Older 
 Protocol: Epidemiology of Hospital Acquired Methicillin-Resistant Staphylococcus aureus 
in a Veterans Affairs Medical Center Spinal Cord Injury Unit: Fiscal Years 2008-2011  
Chart Reviewer:   Rebecca B. Stone 
 Date of Validation of MRSA Cases: ____________________ 
(Adapted from CDC/NHSN Surveillance Definitions) 
Infection (Body Site) Clinical Criteria Yes No 
SSI- Surgical Site 
Infection (superficial, 
primary or secondary site) 
Must meet the following criteria:  
 
 
 
Infection occurs w/I 30 days after operative 
procedure 
and 
involves only skin and subcutaneous tissue of 
the incision 
And at least 1 of the following: 
      a. purulent drainage from incision 
      b. organisms isolated from an aseptically    
      obtained culture of fluid or tissue from  
      incision 
      c. at least 1 of the following signs and    
      symptoms of infection: 
           a. pain or tenderness 
           b. localized swelling 
           c. redness or heat 
           d. incision deliberately opened by  
           surgeon & is culture positive or not  
           cultured (culture negative finding does   
           not meet this criterion) 
           e. diagnosis of infection by surgeon or  
           attending physician 
 
  
SSI- (deep incisional-
primary or secondary site) 
Must meet the following criteria:   
 
Infection occurs w/I 30 days after operative 
procedure if no implant is left in place or w/I 
1 yr. if implant is in place and the infection 
appears to be related to the operation 
and  
involves deep soft tissue of the incision 
  
EPIDEMIOLOGY of HA-MRSA 
  
 
102 
 
And at least 1 of the following: 
      a. purulent drainage from incision but not  
      the organ space 
      b. deep incision spontaneously dehisces    
      or deliberately opened by the surgeon and  
      is culture positive or not cultured when  
      the patient has at least 1 of the following  
      signs and symptoms: 
           a. pain or tenderness 
           b. fever 
           c. abscess or evidence of infection  
           involving the deep incision on direct  
           examination/reoperation or by  
           histopathology or radiology exam 
           d. diagnosis of infection by surgeon or  
           attending physician 
 
SSI- (Organ/Space) Must meet the following criteria:   
 
Infection occurs w/I 30 days after the 
operation if no implant is left in place or w/I 
1 yr. if implant is in place and the infection 
appears to be related to the operation 
and 
infection involves any part of the body, 
excluding the skin incision, fascia, or muscle 
layers that is opened during the operation 
and 
patient has at least 1 of the following: 
      a. purulent drainage from a drain placed  
      through a stab wound into the organ/space 
      b. organisms isolated from an aseptically  
      obtained culture of fluid or tissue in the  
      organ/space 
      c. abscess or other evidence of infection  
      found on direct exam, during reoperation,  
      histopathologic or radiologic exam 
      d. diagnosis by surgeon or attending   
      physician 
  
BSI-Blood Stream 
Infection(LCBI-
Laboratory-confirmed 
bloodstream) 
Must meet at least 1 of the following criteria   
 
1. Recognized pathogen cultured from 1 or 
more blood cultures 
and 
organism is not related to an infection at 
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another site 
2. At least 1 of the following signs & 
symptoms: 
      a. fever 
      b. chills 
      c. hypotension 
      d. signs and symptoms and positive  
      culture are not related to an infection at  
      another site 
      e. common skin contaminant cultured  
      from 2 or more blood cultures drawn on  
      separate occasions 
 
Central Line-Associated 
Blood Stream Infection 
(CLABSI) 
1. A laboratory-confirmed bloodstream 
infection (LCBI) where central line (CL) or 
umbilical catheter (UC) was in place for >2 
calendar days when all elements of the LCBI 
infection criterion were first present together, 
with day of device placement being Day 1,  
AND 
2. A CL or UC was in place on the date of 
event or the day before. If the patient is 
admitted or transferred into a facility with a 
central line in place (e.g., tunneled or implanted 
central line), day of first access is considered 
Day1.  
  
 
Comments: 
1. Neither the insertion site nor the type of 
device may be used to determine if a line 
qualifies as a central line. The device must 
terminate in one of the great vessels or in or 
near the heart and be used for one of the 
purposes outlined above, to qualify as a central 
line.  
2. An introducer is considered an intravascular 
catheter, and depending on the location of its 
tip and use, may be a central line.  
3. Pacemaker wires and other nonlumened 
devices inserted into central blood vessels or 
the heart are not considered central lines. 
  
BJ-Bone & Joint Infection 
(osteomyelitis) 
≥ 1 of the following criteria:   
 
1. Organism cultured from bone 
2. Evidence of osteomyelitis on direct exam 
of bone during a surgical operation or 
histological exam 
3. ≥2 of the following signs and symptoms 
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with 
no other recognized cause: 
     a. fever (>38º C) 
     b. localized swelling 
     c. tenderness 
     d. heat 
     e. drainage at suspected site 
And at least 1 of the following: 
     a. organism cultured from blood 
     b. radiographic evidence of infection 
BJ- (Joint or Bursa) ≥ 1 of the following criteria:   
 
1. Organism cultured from joint fluid or 
synovial biopsy 
2. Evidence of joint or bursa infection seen 
during a surgical operation or histological 
exam 
3. ≥2 of the following 
     a. joint effusion 
     b. swelling 
     c. tenderness 
     d. heat 
     e. evidence of effusion 
     f. limitation of motion 
And at least 1 of the following: 
     a. organisms and WBCs seen on Gram's 
     stain of joint fluid 
     b. positive antigen test on blood, urine, or 
     joint fluid 
     c. cellular profile and chemistries of joint 
     fluid consistent w/infection and not 
     rheumatologic disorder 
     d. radiographic evidence of infection 
  
Disc Space Infection Must meet at least 1 of the following criteria:   
 
1. Patient has organisms cultured from 
vertebral disc space obtained during a 
surgical procedure or aspiration 
2. Evidence of disc infection during a surgical 
operation or histopathological exam 
3. Signs and symptoms: 
     a. fever 
     b. pain at the disc space  
and 
     c. radiographic evidence of infection 
4. Signs and symptoms: 
     a. fever  
     b. pain at the involved disc space 
  
EPIDEMIOLOGY of HA-MRSA 
  
 
105 
 
CNS-Central Nervous 
System (intracranial 
infection-brain abscess, 
sub or epidural infection, 
encephalitis) 
At least 1 of the following must be met:   
 
 
1. Patient has organisms cultured from brain 
tissue or dura.  
2. Patient has an abscess or evidence of 
intracranial infection seen during a 
surgical operation or histopathologic 
examination.  
3. Patient has at least 2 of the following 
signs or symptoms with no other 
recognized cause: 
a.  headache 
b. dizziness 
c. fever  
d. localizing neurologic signs 
e. changing level of consciousness, or 
confusion  
and at least 1 of the following:  
     a. organisms seen on microscopic      
     examination of brain or abscess tissue  
     obtained by needle aspiration or by biopsy  
     during a surgical operation or autopsy  
     b. positive antigen test on blood or urine  
     c. radiographic evidence of infection  
and  
if diagnosis is made antemortem, physician 
institutes appropriate antimicrobial therapy.  
 
  
CNS-(meningitis) At least 1 of the following must be met:   
 
1. organism cultured from CSF 
2. At least1 following S&S: 
     a. fever (>38 ºC) 
     b. headache 
     c. stiff neck 
     d. meningeal signs 
     e. cranial nerve signs 
     f. irritability 
AND ≥1 of the following: 
     a. increased white cells, elevated protein, 
     and/or decrease glucose in CSF 
     b. organism seen on Gram's stain of CSF 
     c. organism cultured from blood 
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     AND if diagnosis is antemortem,      
     physician institutes antimicrobial therapy 
CNS - (spinal abscess w/o 
meningitis  
   
 
Abscess of the spinal epidural or subdural 
space w/o involvement of the CSF or 
adjacent bone  
1. Organism cultured from abscess in the 
spinal 
epidural or subdural space 
2. Abscess in spinal epidural or subdural 
space 
seen during surgery or histo exam 
3. ≥1 following signs and symptoms 
     a. fever (38 ºC) 
     b. back pain 
     c. focal tenderness 
     d. radiculitis 
     e. paraparesis 
     f. paraplegia 
AND ≥1 of the following: 
     a. organism cultured from blood 
     b. radiographic evidence of spinal abscess 
     AND if diagnosis is antemortem,     
     Physician institutes antimicrobial therapy 
  
CVS-Cardiovascular 
System Infection(arterial 
or venous) 
At least 1 of the following must be met:  
 
 
 
1. Organism cultured from arteries or veins 
removed during surgical operation and, blood 
culture not done or no organism cultured 
from blood 
2. Evidence of arterial or venous infection 
seen during a surgical operation on 
histological exam 
3. ≥1 of following S&S 
a. fever (>38 deg C) 
b. pain 
c. erythema 
d. heat at involved vascular site 
and more than 15 colonies cultured from 
intravascular cannula tip and BC not done or 
no organisms cultured from blood 
4. Purulent drainage at involved vascular site 
5. ≥1 of the following S&S: 
     a. fever (>38 deg C) 
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     b. hypothermia (<37 deg C) 
     c. apnea 
     d. bradycardia 
     e. lethargy 
     f. pain 
     g. erythema 
     h. heat at vascular site 
     and more than 15 colonies cultured from 
     intravascular cannula tip and BC not done      
     or no organisms cultured from blood 
     and more than 15 colonies cultured from 
     intravascular cannula tip and BC not done    
     or no organisms cultured from blood 
CVS - (endocarditis, valve 
disease, due to a device, 
implant or graft) 
At least 1 of the following must be met:   
 
1. organism cultured from valve or vegetation 
2. ≥2 of the following S&S: 
     a. fever (>38 ºC) 
     b. new or changing murmur 
     c. embolic phenomena 
     d. skin manifestations (for example: 
     petechiae, splinter hemorrhages, painful 
     subcutaneous nodules) 
     e. CHF 
     f. cardiac conduction abnormality 
and ≥1 of the following: 
     a. organism cultured from ≥2 blood      
     cultures 
     b. organism seen on Gram's stain of valve 
     when culture is negative or not done 
     c. valvular vegetation seen during a sx 
     procedure or autopsy 
     d. evidence of new vegetation seen on    
     echo 
and ≥1 of the following: 
      if diagnosis is made antemortem, or 
      physician institutes appropriate 
     antimicrobial treatment 
  
CVS -
(myocarditis/pericarditis) 
At least 1 of the following must be met:   
 
1. Organism cultured from pericardial tissue 
or fluid 
2. ≥2 of the following S&S: 
     a. fever 
     b. chest pain 
  
EPIDEMIOLOGY of HA-MRSA 
  
 
108 
 
     c. paradoxical pulses 
     d. increased heart size 
and at least 1 of the following: 
     a. abnormal EKG consistent with    
     myocarditis or pericarditis 
     b. evidence of myocarditis or pericarditis    
     on histo exam  
     c. pericardial effusion 
 
 
CVS- (mediastinitis) At least 1 of the following must be met:   
 
1. organisms isolated by culture during 
surgical procedure or needle aspiration 
2. evidence of infection seen during operation 
or histopathological examination 
3. ≥1 of the following S&S: 
     a. fever 
     b. chest pain 
     c. sterna instability 
and at least 1 of the following: 
     a. purulent discharge 
     b. positive culture from blood or discharge   
     from mediastinal area 
     c. mediastinal widening on x-ray 
 
  
EENT- Eye, Ear, Nose, 
Throat, or Mouth 
Infection 
At least 1 of the following must be met:   
 
1. pathogens cultured from purulent exudates 
2. pain or redness of conjunctiva 
and at least 1 of the following: 
     a. WBC’s and organisms seen on Gram    
     stain 
     b. purulent discharge 
3. Infection of eye other than conjunctivitis: 
     a. physician diagnosis of eye infection 
     b. organism cultured from blood 
  
EENT - (ear mastoid) At least 1 of the following must be met:   
 
Otits externa: 
1. pathogen isolated from purulent drainage 
from ear canal 
2. and ≥1 of the following S&S: 
     a. fever 
     b. pain 
     c. redness 
     d. drainage from ear canal 
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and 
     a. organisms seen on gram stain from   
     drainage 
Otitis media: 
1. pathogen isolated from fluid from middle 
ear 
2. and ≥2 of the following S&S: 
     a. fever 
     b. pain 
     c. inflammation 
     d. retraction or decreased mobility of   
     eardrum  
     e. fluid behind eardrum 
Otitis interna: 
1. pathogen isolated from inner ear 
2. physician diagnosis 
Mastoiditis: 
1. pathogen isolated from purulent drainage 
of mastoid 
2. and ≥2 of the following S&S: 
     a. fever 
     b. pain 
     c. tenderness 
     d. erythema 
     e. headache 
     f. facial paralysis 
and at least 1 of the following 
     a. organism seen on gram stain 
 
EENT - (oral cavity-
mouth, tongue, gums) 
At least 1 of the following must be met:   
 
1. pathogen isolated from tissues in oral 
cavity 
2. abscess or evidence or oral cavity infection 
on examination 
3. and ≥1 of the following S&S: 
     a. abscess 
     b. ulceration 
and at least 1 of the following 
     a. organisms seen on gram stain 
     b. physician diagnosis and treatment 
 
  
EENT-  (Sinusitis) At least 1 of the following must be met:   
 
1. organisms isolated by culture from 
purulent drainage 
2. at least 1 of the following S&S: 
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     a. fever 
     b. pain 
     c. tenderness over sinus 
     d. purulent exudates 
     e. nasal obstruction 
and at least 1 of the following: 
     a. positive transillumination 
     b. positive radiographic exam 
GI-Gastrointestinal 
Infections (gastroenteritis) 
At least 1 of the following must be met:   
 
1. acute onset of diarrhea with or w/o 
vomiting or fever, and not likely 
noninfectious cause 
2. At least 2 of the following S&S: 
     a. nausea 
     b. vomiting 
     c. abdominal pain 
     d. fever 
     e. headache 
  
IAB – Intraabdominal 
Infection (gallbladder, bile 
ducts, liver, spleen, 
pancrease) 
At least 1 of the following must be met:   
 
1. organism cultured from purulent material 
from IAB space 
2. Abscess or other evidence of IAB infection 
3. ≥2 of the following S&S: 
     a. fever (>38 ºC) 
     b. nausea 
     c. vomiting 
     d. abdominal pain 
     e. jaundice 
AND ≥1 following: 
     a. organism from drainage from surgically 
     placed drain 
     b. organism seen on Gram's stain of       
     drainage or tissue 
     c. organism cultured from blood or 
     radiographic evidence of infection 
  
UR – Upper Respiratory 
Tract ( pharyngitis, 
laryngitis, epiglottitis) 
At least 1 of the following must be met:   
 
1. ≥2 of the following S&S: 
     a. fever 
     b. erythema of pharynx 
     c. sore throat 
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     d. cough 
     e. hoarsenss 
     f. purulent throat exudates 
and at least 1 of the following: 
     a. organisms isolated from the specific site 
     b. organisms isolated from blood 
     c. physician diagnosis of infection 
2. abscess seen on direct examination 
LRI-Lower Respiratory 
Tract Infection, Other 
than Pneumonia 
(bronchitis, bronchiolitis, 
tracheitis, w/o evidence of 
pneumonia) 
Must meet at least 1 of the following:   
 
1. no clinical or radiographic evidence of 
pneumonia 
and at least 2 of the following S&S: 
     a. fever 
     b. cough 
     c. new or increased sputum production 
     d. rhonchi 
     e. wheezing 
and at least 1 of the following: 
     a. positive culture obtained by deep  
     tracheal aspirate or bronchoscopy 
  
OREP-Reproductive 
Tract Infection (other 
infections of the 
reproductive tract) 
Must meet at least 1 of the following:   
 
1. organisms isolated from the affected site 
2. abscess or evidence of infection  
3. at least 2 of the following S&S: 
     a. fever 
     b. nausea 
     c. vomiting 
     d. pain 
     e. tenderness 
     f. dysuria 
and 
     a. organisms cultured from the blood 
     b. physician diagnosis 
  
SST-Skin & Soft Tissue 
Infection (cellulitis/soft 
tissue/wound infection) 
Must meet at least 1 of the following:   
 
1. Purulent draining, pustules, vesicles, or 
boils 2. ≥2 of the following with no other 
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recognized 
cause: 
     a. pain or tenderness 
     b. localized swelling 
     c. redness 
     d. heat 
AND ≥1 of following: 
     a. organism cultured from site 
     b. organism cultured from blood 
Soft Tissue (necrotizing 
fascitis, infectious 
gangrene, necrotizing 
cellulitis, infectious 
myositis, lymphadenitis, 
or lymphangitis) 
One of the following must be met:   
 
1. Organism cultured from site 
2. Purulent drainage at site 
3. Abscess or other signs of infection 
observed during surgical operation or 
histological exam 
4. ≥2 of the following characteristics 
     a. organism cultured from blood 
 
  
SST-Decubitus ulcer, 
including superficial and 
deep infections 
At least 2 of the following signs and 
symptoms with no other recognized causes: 
  
 
1. redness 
2. tenderness 
3. swelling of decubitus wound edges 
And ≥1 of the following: 
     a. organism cultured from properly          
     collected fluid or tissue 
     b. organism cultured from blood 
     Purulent drainage alone is not sufficient     
     Evidence of decubitus ulcer. Properly   
     collected specimen involves needle   
     aspiration of fluid or biopsy of 
     tissue from ulcer margin. 
  
SYS-Systemic Infection    
 
Involves multiple organs or systems w/o an 
apparent single site infection. 
  
Urinary Tract Infection-
UTI 
   
Symptomatic Urinary 
Tract Infection-SUTI 
Patient must meet at least 1 of the following 
criteria: 
  
 
1. Patient has at least 1 of the following signs   
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or symptoms with no other recognized cause: 
fever (>38C), urgency, frequency, dysuria, or 
suprapubic tenderness 
And 
Patient has a positive urine culture, greater 
than 100,000 microorganisms per cc of urine 
with no more than 2 species of 
microorganisms. 
2. Patient has at least 2 of the following signs 
or symptons with no other recognized cause: 
fever (>38C), urgency, frequency, dysuria, or 
suprapubic tenderness 
AND at least 1 of the following: 
     a. positive dipstick for leukocyte esterase  
     and/nitrate 
     b. pyuria (urine with >10WBC high power  
     field of unspun urine) 
     c. organisms seen on Gram’s stain of  
     unspun urine 
     d. at least 2 urine cultures with repeated  
     isolation of the same uropathogen (gram  
     negative bacteria or Staphylococcus  
     saprophyticus) with >20,000 colonies/ml  
     in non-voided specimens 
     e. < 100,000 colonies/ml of a single  
     uropathogen (gram negative or  
     Staphylococcus saprophyticus) in a patient  
     being treated with an effective  
     antimicrobial agent for a urinary tract  
     infection 
     f. physician diagnosis of a urinary tract  
     infection 
     g. physician institutes appropriated  
     therapy for a urinary tract infection 
 
OUTI-Other Infection of 
the UTI (kidney, ureter, 
urethra, tissue 
surrounding the retro-
peritoneal) 
Patient has at least 1 of the following criteria:   
 
1. Positive culture from fluid other than urine 
or tissue from affected site 
2. An abscess or other evidence of infection 
on examination during surgical operation or 
histopathologic examination 
3. ≥ 2 of the following signs   
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       and symptons: 
       a. fever (>38 deg C) 
       b. localized pain 
       c. localized tenderness at the involved   
       site 
 
And at least 1 of the following: 
      a. purulent drainage from site 
      b. organisms cultured from blood that are    
      compatible with suspected site of  
      infection 
      c. radiographic evidence of infection 
      d. physician diagnosis of infection of the   
      kidney, urethra, or tissues surrounding the  
      retroperitoneal or perinephric space 
      e. physician begins appropriate therapy    
      for infection of the kidney, ureter,  
      bladder, utethra, or tissues surrounding    
      the retroperitoneal or perinephric space 
 
Asymptomatic 
Bacteriuria-ASB 
Patient has at least 1 of the following criteria:   
 
1. Patient has had an indwelling urinary 
catheter within 7 days before the culture 
AND 
Patient has a positive urine culture, that is, 
>100,000 organisms per cc of urine with no 
more than 2 species of organisms 
AND 
Patient has no fever (>38C), urgency, 
frequency, dysuria, or suprapubic tenderness. 
2. Patient has not had an indwelling urinary 
catheter within 7 days before the first positive 
culture 
AND 
Patient has had at least 2 positive urine 
cultures, that is, >100,000 organisms per cc 
of urine with repeated isolation of the same 
microorganism and no more than 2 species of 
microorganisms 
AND 
Patient has no fever (>38C), urgency, 
frequency, dysuria, or suprapubic tenderness. 
Comments: A positive culture of a urinary 
catheter tip is not an acceptable laboratory 
test to diagnose a urinary tract infection. 
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C. IRB Approval Letter 
 
 
 
 
Date: 10/18/2012  
HAC File #: 
Pro00000773 , Stone Epidemiology of Hospital Acquired Methicillin-Resistant 
Staphylococcus aureus in a Veterans Affairs Medical Center Spinal Cord Injury 
Unit: Fiscal Years 2008-2011 
Protocol Title 
 
Epidemiology of Hospital Acquired Methicillin-Resistant Staphylococcus 
aureus in a Veterans Affairs Medical Center Spinal Cord Injury Unit: Fiscal 
Years 2008-2011 
PI Name Rebecca Stone  
Approval 
Date 10/16/2012 
Expiration 
Date 10/15/2013 
The Human Assurance Committee (HAC) chairperson or designee reviewed and approved the 
referenced study and enclosed document(s) by the expedited procedure in accordance with the 
Department of Health and Human Services (DHHS) policy and the Institutional Assurance on 
file with the DHHS under the following criteria: 
(5) Research involving materials (data, documents, records, or specimens) that have been 
collected, or will be collected solely for nonresearch purposes (such as medical treatment or 
diagnosis). (Note: Some research in this category may be exempt from the HHS regulations for 
the protection of human subjects, 45 CFR 46.101(b)(4). This listing refers only to research that 
is not exempt.) 
 
Approval has been granted for waiver of consent and waiver of HIPAA Authorization in 
accordance with the Department of Health and Human Services DHHS) policy, the Institutional 
Assurance on file with the DHHS and the Health Insurance Portability and Accountability Act 
(HIPPA) policy because: 
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1. The research involves no more than minimal risks to subjects.  
2. The alteration or waiver of consent will not adversely affect the privacy rights and 
welfare of the individuals.  
3. The research could not practicably be carried out without access to and use of the 
protected health information.  
4. The research could not practicably be carried out without the waiver or alteration.  
5. The privacy risks to individuals whose protected health information is to be used or 
disclosed are reasonable in relation to the anticipated benefits, if any, to the individuals, 
and the importance of the knowledge may reasonably be expected to result from the 
research.  
6. There is an adequate plan to protect the identifiers from improper use and disclosure.  
7. There is an adequate plan to destroy identifiers at the earliest opportunity consistent with 
the conduct of the research unless there is a health or research justification for retaining 
the identifiers, or such retention is required by law.  
8. There are adequate written assurances that the protected health information will not be 
reused or disclosed to any other entity or person except as required by law, for authorized 
oversight of the research project, or for other research for which the use of disclosure of 
the protected information will be permitted.  
The approval includes the following supporting documents 
MRSA Data Collection Form.pdf 10/16/2012 0.01 
 
The Committee calls your attention to the following obligations as Principal Investigator of this 
study. Under the terms of our approved Institutional Assurance to the Department of Health and 
Human Services, you must provide the HAC with a progress report at the termination of the 
study, or prior to the expiration of this approval, whichever comes first. If the study will continue 
beyond the initial approval term, review by the Human Assurance Committee is required, with a 
progress report constituting an important part of the review.  
Failure to submit a Continuation Request by its due date will result in an automatic termination 
of this study. Reinstatement will only be granted following resubmission of the study to the 
HAC. 
The HAC has determined that the interval of continuing review as noted by the approval and 
approval expiration dates above is appropriate to the degree of risk for this protocol. 
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If Veterans Affairs (VA) patients or facilities will be involved in this study, a letter of 
approval from the VA Research & Development Committee must also be obtained prior to 
involvement of VA patients or facilities. You must also contact the VA regarding their 
disclosure reporting requirements. 
Please feel free to contact our office at 706-721-3110 if you have any questions. 
Warning: This is a private message for eIRB users only. If the reader of this message is not the 
intended recipient you are hereby notified that any dissemination, distribution or copying of 
this information is STRICTLY PROHIBITED. 
Human Assurance Committee (HAC) 
Georgia Health Sciences University 
1120 15th St., CJ-2103 
Augusta GA 30912-7621 
HAC@georgiahealth.edu 
Office 706-721-3110http://www.georgiahealth.edu/research/ohrp/irb/hac/index.html 
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